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INTRODUCTION 
 
Background 
Hemodialysis (HD) is available since the early 1950’s and has gained tremendous techni-
cal improvements since then. To date, there are approximately 9500 end-stage-renal-
disease (ESRD) patients in the Netherlands. Thirty-five percent of them is depending on 
some form of hemodialysis. On average, this means that they are treated thrice weekly 
during a 4-hour session. Hemodialysis treatment is accompanied by a wide variety of 
complications. The dialysis population is changing over the years, increasing in age and 
comorbidity, such as diabetes mellitus, affecting cardiovascular stability.  
Despite all technical improvements, one of the most frequent complications remains in-
tradialytic hypotension (IDH), occurring in up to 20% of dialysis sessions. IDH is defined 
as a symptomatic decrease of more than 30 mmHg in systolic blood pressure or as an 
absolute systolic blood pressure under 90 mmHg. Decades of research revealed that the 
cause of IDH is multifactorial. First described in 1970 (1), Bergström showed in 1978 
that intravascular hypovolemia, due to a large volume of ultrafiltration in too short a pe-
riod of time, was not the sole cause of IDH (2). There is a difference in blood pressure 
stability between isolated ultrafiltration and hemodialysis (3). Hemodialysis is the com-
bination of ultrafiltration of fluid excess and the clearance of solute waste products 
such as urea by diffusion. Dialysis without ultrafiltration rarely causes IDH. Therefore, it 
can be concluded that IDH occurs when normal compensatory mechanisms cannot cope 
with the removal of intravascular fluid in a short period of time in a specific patient.  
Negative effects of IDH are the discomfort for the patient and the decline in efficacy of 
HD due to interventions such as interruption of HD and the necessity for intravenous 
infusions. More importantly, a recent study reports increased mortality in hypotension 
prone hemodialysis patients (4). Therefore, reducing intradialytic hypotension remains a 
challenge. The factors playing a role in the pathogenesis of IDH will be outlined. Patient 
related data will prove to be essential in this dilemma.  
This thesis is aimed at collecting and interpreting bedside hemodynamic parameters, to 
define the pathogenesis of IDH and thereby to apply the most appropriate protective 
strategies for the hypotension prone hemodialysis patient on an individual basis.  
 
Normal compensatory response on hemodialysis. 
In end stage renal disease (ESRD) patients, fluid accumulation will occur between two 
hemodialysis sessions. This excess fluid will be situated mainly in the extracellular com-
partment and has to be removed during a hemodialysis session. Often the amount of 
fluid that has to be removed equals the amount of the plasma volume and has to be 
withdrawn from the intravascular compartment within a short period of time. During 
hemodialysis fluid will be removed from the intravascular compartment by ultrafiltration 
resulting in a loss of iso-osmotic fluid (water and solutes). Thus, intravascular hypo-
volemia may ensue from intravascular fluid and solute loss. There are several mecha-
nisms counteracting the consequent relative intravascular hypovolemia, thereby aiming 
to preserve adequate blood pressure. Failure of these compensatory mechanisms leads 
to intradialytic hypotension. 
 
Plasma refilling 
To maintain adequate blood pressure, capillary plasma refilling counteracts ultrafiltra-
tion induced hypovolemia. Plasma refilling from the extracellular compartment towards 
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the intravascular compartment is driven on the one hand by a reduced intravascular hy-
drostatic pressure due to the loss of iso-osmotic fluid and, on the other hand, due to an 
increased intravascular oncotic pressure due to  ultrafiltration resulting in a rise in se-
rum albumin. Because there is some delay in refilling, the magnitude of intravascular 
hypovolemia is influenced by the rate and amount of the ultrafiltration volume. The 
hereby induced relative hypovolemia plays a central role in subsequent intradialytic 
complications such as hypotension (5). The magnitude of the intravascular hypovolemia 
can be reduced by minimizing the volume necessary to be withdrawn. The ultrafiltration 
volume is determined by the interdialytic weight gain. Thus, aiming at the smallest in-
terdialytic weight gain achievable by the patient is of supreme importance. Furthermore, 
an adequate assessment of the dry weight to be achieved at the end of HD is essential.  
 
Cardiac adjustment 
Normal compensatory cardiac mechanisms to prevent hypovolemia are an increase in 
heart rate and contractility. During hypovolemia an increase in heart rate, caused by 
beta-adrenergic activation, is of relatively minor importance in maintaining blood pres-
sure (6). Thus, diminished ability to increase contractility will cause increased sensitivity 
to hypovolemia. In addition, there is a high prevalence of congestive heart failure in 
ESRD patients (7). Due to chronic fluid and pressure overload, left ventricular hypertro-
phy is frequently present. This typically causes diastolic dysfunction, resulting in an un-
usual sensitivity to changes in intravascular volume (8). When the venous return to the 
heart is diminished, the ventricles will contract around an almost empty chamber, 
thereby eliciting the Bezold-Jarisch reflex. This is a cardio-inhibitory reflex to prevent 
myocardial damage in case of extreme intracardial hypovolemia (9). The resulting bra-
dycardia together with the present hypovolemia may cause hypotension. Thus, the ef-
fect of a less compliant heart is augmented in a situation of hypovolemia. This results in 
increased risk of IDH in cardiac compromised patients.  
 
Venous tone 
Centralization of blood volume during hypovolemia occurs by means of passive veno-
constriction. This is called the De-Jager-Krogh phenomenon, meaning that due to dimin-
ished arterial blood supply in a state of hypovolemia, venous capacitance beds will con-
tract because of reduced distending pressure, thereby preserving cardiac filling (10,11). 
When arteriolar vascular resistance fails to increase, the distending pressure transferred 
to the capillary and venous system is preserved. Passive recoil of the venous capaci-
tance bed will be impeded, thereby diminishing venous return to the heart and thus car-
diac filling.  
 
Systemic vascular resistance 
Active arterial vasoconstriction preserves blood pressure. Adequate autonomic function 
is necessary to enable vasoconstriction. During uncomplicated hemodialysis, no change 
in autonomic function is observed (12). However, general autonomic neuropathy is fre-
quently present in ESRD patients, and a relation between autonomic neuropathy and IDH 
was already suggested in 1974 (13,14). In HD complicated by hypotension, a paradoxi-
cal sympathetical withdrawal was reported (15), possibly as a result of activation of the 
Bezold-Jarisch reflex caused by critical cardiac underfilling.  Another factor reported to 
play a role is release of counterproductive vasodilating substances during hemodialysis. 
For instance, adenosine is thought to be released during tissue ischemia, occurring un-
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der hypovolemia (16). Nitric oxide (NO), a potent vasodilator, is shown to be increased 
in dialysis hypotension (17,18). The etiology of this release of vasodilating agents has 
not been clarified. 
 
For years IDH is thought to be multifactorial in its origin. Different aspects of normal 
compensatory responses can fail, causing intradialytic hypotension. Because of the 
close interactions between the several blood pressure regulating mechanisms, disentan-
gling the origin of the hypotension can be difficult. The main focus has been on dialy-
sis-related aspects, currently shifting towards patient-related aspects. With a hemodialy-
sis population increasing in age and comorbidity, patient-related causes of IDH become 
more important. Therefore, bedside patient-related information is needed in order to 
influence dialysis related parameters, aiming at alleviating IDH for the individual hemo-
dialysis patient and mitigating the detrimental effect on dialysis efficacy and, thereby, 
improving long term survival.  
Described below are the noninvasive techniques, by means of which we measured or 
derived the most important hemodynamic parameters. Blood pressure was measured by 
an automatic cuff sphygmomanometer. Simultaneously stroke volume and heart rate are 
monitored by means of electrical impedance cardiography. Thus, cardiac adjustments 
before and during hypotensive episodes could be interpreted. Vascular resistance re-
sponse were determined from changes in cardiac output in comparison to blood pres-
sure changes. Together with impedance-derived calculation of extracellular water and 
total body water, concomitant blood volume and ultrafiltration monitoring provided in-
formation about volume status and the degree of hypovolemia.  
 
Methods 
Electrical Impedance Cardiography (EIC) 
Electrical Impedance Cardiography is a method to non-invasively measure cardiac stroke 
volume. It is based on Ohm’s law: V = I * R, i.e. voltage is electrical current strength 
times resistance. When a current with a known strength is applied between two elec-
trodes and the voltage is measured, resistance can be calculated. When an alternating 
current is used, resistance is called impedance (Z). The human thorax can be considered 
as a conductive structure of which the thoracic tissues provide a basic impedance signal 
and the pulsatile blood flow provides a superimposed changing signal. Since the intra-
thoracic blood volume increases with every cardiac ejection, the thereby decreasing im-
pedance reflects stroke volume. This beat-to-beat impedance variation can be averaged 
over a period of heartbeats, resulting in a specific waveform signal (Figure 1).  
With the equation of Kubicek (19,20), stroke volume can be calculated from the first de-
rivative of this signal. In practice, to obtain impedance changes over the thorax due to 
cardiac activity, four electrode levels are applied in a 9-electrode configuration as de-
scribed by Woltjer et al. (21) (Figure 2). The outer two levels are the current applying 
electrodes and the inner two levels detect the voltage changes over the thorax: two elec-
trodes are placed at the base of the neck and two electrodes in the midaxillary lines at 
the level of the xiphoid. All electrodes in one level being electrically connected, an alter-
nating current of 0.8 mA RMS and 60 kHz is passed through the current applying elec-
trodes and impedance is calculated using Ohm’s law. Simultaneously with the imped-
ance recordings, lead I of the ECG is recorded and mean arterial blood pressure (MAP) is 
measured every 10 minutes using a cuff sphygmomanometer. Cardiac output (CO) is 
calculated as stroke volume (SV) times heart rate (HR), and systemic vascular resistance 
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(SVR) as (MAP/CO) * 80, expressed as dynes/s/cm-5. Thus, a complete hemodynamic im-
pression can be obtained during hemodialysis, especially interesting around hypoten-
sive episodes. 
The technique has been thoroughly validated under various conditions and compared to 
thermodilution, the golden standard of stroke volume measurement (22-27). Also dur-
ing hemodialysis EIC proved its value (28,29). Despite the extensive validation studies, 
the technique has not been generally accepted for hemodynamic monitoring during HD 
thus far. Few studies have used EIC to clarify individual causes of IDH (28-30). However, 
several recent studies encourage the use of EIC in different clinical settings, such as the 
Cardiology and the Emergency Departments (31-34). In this thesis the value of EIC in 
hemodialysis patients will be re-emphasized.  
Figure 1. Characteristic signal of Electrical    Figure 2. Electrode configuration in 
Impedance Cardiography      Electrical Impedance Cardiography 
          
Continuous blood volume monitoring (BVM) 
Assuming that changes in blood volume during HD only occur because of extracorpo-
real ultrafiltration and vascular refilling, blood volume will decrease when the ultrafiltra-
tion rate exceeds vascular refilling rate. An optical device was used in order to monitor 
variations in blood volume during HD continuously and non-invasively, as described by 
De Vries et al. (35). This method is based on the principle of infrared light propagation 
in whole blood. A part of this light will be reflected by erythrocytes as a result of scat-
tering (36). The amount of reflected light detected is directly proportional to the con-
centration of blood cells in whole blood. Because erythrocyte concentration is recipro-
cally related to blood volume, the variations in blood volume can easily be calculated 
using the data derived from the optical device. It has been hypothesized that continu-
ous monitoring of blood volume changes can reduce intradialytic symptoms by setting 
an individual hematocrit threshold (37). On the other hand, IDH has been shown to oc-
cur even with minimal blood volume decrease, emphasizing the multifactorial character 
of IDH (38). 
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Bioimpedance Analysis (BIA) 
Dry weight is an important parameter in hemodialysis, because the ultrafiltration vol-
ume is the difference between the actual predialysis weight and the assumed dry 
weight, achieved post dialysis. Clinical assessment still plays a major role in this deter-
mination. Several techniques have been studied to assess dry weight more objectively 
and more accurately. Echocardiography of the inferior vena cava has been mentioned as 
a reliable tool (39,40). Bioimpedance analysis has also proven to be a promising method 
for determining dry weight (39,41). 
With four electrodes applied over the wrist and the ipsilateral ankle an electrical field is 
induced in the patient. Total body resistance (R) and reactance (Xc) can be calculated 
from the measured voltages. The resistance is directly correlated to total body water 
and the reactance to intracellular water. Thus, the hydration state can be monitored 
noninvasively. Combined with hemodynamic parameters during hemodialysis, this pro-
vides more insight in fluid shifts caused by hemodialysis. For instance, the degree of 
blood volume decrease in relation to ultrafiltration volume is a measure for capillary re-
fill rate and signals the presence of over- or underhydration. Furthermore, post dialysis 
dry weight can be established more accurately by using reference values for normohy-
dration in healthy subjects.  
 
Aims of the study 
Identifying the most prominent cause of IDH in every hypotension prone patient indi-
vidually may lead to a tailor-made, individualized dialysis strategy. Measuring hemody-
namic parameters in the individual patient provides the opportunity to classify the pa-
tient in different risk categories, enabling specific therapy. 
What is needed is bedside patient-related information in order to influence dialysis re-
lated parameters, aiming at alleviating IDH for the individual HD patient and mitigating 
the detrimental effect on dialysis efficacy and, thereby, improving long-term survival. 
Gathering reliable hemodynamic parameters during frequent short sessions, without 
extra burden for the dialysis patient, is difficult. Electrical Impedance Cardiography (EIC) 
provides a tool for noninvasive bedside monitoring of intradialytic hemodynamics. 
In chapter 2 we describe several hemodynamic changes during hemodialysis 
leading to hypotension using noninvasive monitoring devices. Alterations in blood vol-
ume are measured, as well as changes in stroke volume (SV) and heart rate (HR), form-
ing cardiac output (CO). Combined with blood pressure measurements, responses in 
systemic vascular resistance can be calculated. Description of these hemodynamic 
changes during dialysis will reveal more about the initiation of hypotension and the fac-
tors affecting it. 
Chapter 3 is aimed at subgroup analysis of hypotension prone patients. An at-
tempt will be made to provide a classification of the individual hypotension prone pa-
tient into different causal categories. Since several preventive strategies are available, 
subgroup classification might enable more specific preventive strategies based on ac-
tual measurements.  
Before applying individualized strategies, it is important to know whether these 
individual causes are reproducible within different IDH episodes. Therefore, in Chapter 
4 the reproducibility of the classification of the cause of the hypotensive episode will be 
studied for the individual patient. Several dialysis sessions per patient will be monitored 
to assess reproducibility of hypotension mechanism. 
Chapter 5 describes the quality of the autonomous nervous system in rest in hy-
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potension prone and stable hemodialysis patients. By means of several autonomous 
function tests several parts of the autonomous nervous system are assessed. This study 
aims to identify wheather structural abnormalities in autonomous nervous function play 
a role in causing IDH.  
Finally, in chapter 6 a frequently applied preventive strategy, sodium profiled 
hemodialysis, is tested in its ability to change hemodynamic variables in a beneficial 
way. Attention is paid to avoiding sodium overload, which increases thirst and thereby 
interdialytic weight gain. 
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ABSTRACT 
 
Background. Recurrent intradialytic hypotension still is a major source of discomfort in 
hemodialysis patients today, its origin being subject to extensive research. Different hy-
potheses have been raised to unravel this problem, without forming one coherent point 
of view. The aim of this study was to gain more insight in the mechanisms causing in-
tradialytic hypotension by determining cardiovascular performance non-invasively dur-
ing hemodialysis in a large group of patients. 
Methods. In the present study the variations in blood volume, stroke volume, cardiac 
output and systemic vascular resistance were investigated in sixty-eight patients on 
chronic intermittent hemodialysis utilizing bioelectrical impedance cardiography. In ad-
dition, blood volume was monitored continuously with an on-line optical device. 
Results. Twenty-four patients experienced a symptomatic hypotension during dialysis 
treatment. Compared to the hemodynamically stable patients, the hypotensive patients 
manifested a slightly greater decline in blood volume (mean ± SEM: -9.4 ± 1.2 vs. -6.5 ± 
0.8%, P = 0.04) and cardiac output (-11.8 ± 4.2 vs. -7.3 ± 2.7%, P = NS). The main differ-
ence, however, was a highly significant decrease in systemic vascular resistance (-17.9 ± 
4.4%) in the hypotensive group compared to a rise in the stable group (+6.2 ± 3.5%, P < 
0.001). 
Conclusion. Intradialytic hypotension seems the consequence of an inadequate com-
pensatory response to ultrafiltration-induced blood volume reduction, resulting in a fall 
in systemic vascular resistance. The degree of hypovolemia itself appears to be less im-
portant in the origin of acute, intradialytic hypotensive episodes. Non-invasive monitor-
ing during hemodialysis provides an opportunity to gain more insight in the pathophysi-
ology of intradialytic hypotension and offers the possibility for controlled intervention 
and possible prevention of this complication. 
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INTRODUCTION 
 
Intradialytic hypotension is a major complication in end stage renal disease (ESRD) pa-
tients on chronic intermittent hemodialysis (HD). Despite worldwide efforts to under-
stand their background, up to 30% of these patients still suffer frequently from hypoten-
sive episodes that require intervention and reduce dialysis efficacy (1). Increasing 
knowledge of intradialytic hypotension is of great importance for HD patients, since un-
derstanding the process completely may lead to earlier detection and perhaps even pre-
vention. Several factors contribute to dialysis hypotension, of which hypovolemia has 
long been considered to be the most important factor (2-4). Nowadays, the emphasis is 
shifting more and more towards failing compensatory mechanisms. The two most im-
portant compensation mechanisms are the ability of the heart to maintain cardiac out-
put and a rise in systemic vascular resistance (SVR). Ritz suggested a diastolic left ven-
tricular dysfunction (5), whereas others claimed a role for vasodilating agents such as 
nitric oxide (6). A third option is sympathetic withdrawal during dialysis (7). 
Over the past few decades, electrical impedance cardiography has been developed to a 
non-invasive method to assess stroke volume (SV) and cardiac output (CO) (8). The tech-
nique determines the thoracic impedance changes resulting from the pulsatory cardiac 
pump function. Because of the possibility to perform measurements at the bedside, 
electrical impedance cardiography is suitable for monitoring of SV and CO during HD 
(9). The purpose of the present study was to investigate hemodynamic interactions dur-
ing hemodialysis in order to specify which (patho)physiological mechanisms underlie 
the occurrence of symptomatic hypotensive episodes during HD. Therefore, we studied 
68 patients on chronic intermittent hemodialysis during one HD session by means of 
electrical impedance cardiography to obtain non-invasively values for SV, CO and SVR. In 
addition, a continuous on-line blood volume monitor was used to visualize changes in 
blood volume (BV).  
 
SUBJECTS AND METHODS 
 
Subjects 
A group of 68 patients (38 males; 30 females) on chronic intermittent hemodialysis was 
included in the study. All patients were dialyzed 9-15 hours per week divided over 2-3 
sessions with biocompatible polysulfone membranes, using bicarbonate as buffer and 
heparin as anticoagulant. Blood flow varied from 180 to 300 ml/min, whereas the 
dialysate flow was 500 ml/min and the dialysate sodium concentration 141 mmol/L. Dry 
body weight was determined individually by the attending physician on clinical grounds 
such as blood pressure, peripheral and/or pulmonary edema, and central venous pres-
sure. Ultrafiltration (UF) volume was based on the difference between pre-dialysis and 
dry weight. Patients experiencing a decrease in supine systolic blood pressure during 
dialysis of 30 mmHg or more, or an absolute blood pressure less then 90 mmHg, were 
defined as hypotensive and classified as group H, whereas stable patients formed group 
non-H. To minimize confounding, cardiovascular medication was withheld on the day of 
dialysis. Withdrawal of this medication during a larger period was clinically not accept-
able. Patient characteristics of the two groups are given in Table 1. All patients gave 
their informed consent. 
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Table 1. Characteristics of the hemodynamically stable (non-H) and the hypotension-prone (H) 
patients. 
 
All values are expressed as their mean (SEM). HD = hemodialysis; NS = not significant 
 
Impedance cardiography 
Impedance cardiographic measurements were performed using the IPG-104 impedance 
Mini-Lab (RJL Systems, Detroit, USA, and Equip Medikey, Gouda, The Netherlands). The 
patients were measured every hour or when symptoms of hypotension occurred, such 
as dizziness, frequent yawning or perspiration. The time interval was calculated from 
the start of dialysis until the moment of hypotension for the H group, and compared 
with the non-H group from the start of dialysis until the measurement on average clos-
est to the moment of hypotension in the H group.  
To obtain impedance changes over the thorax due to cardiac activity, four electrode lev-
els were applied according to Woltjer et al. as is shown in Figure 1 (10). The outer two 
levels were the current applying electrodes: the cranial level consisted of one electrode 
on the forehead, whereas the caudal level consisted 
of four electrodes placed semicircularly on the lower 
part of the abdomen, two in the midaxillary lines 
and two in the midclavicular lines. The inner two lev-
els detected the voltage changes over the thorax: 
two electrodes were placed at the base of the neck 
and two electrodes in the midaxillary lines at the 
level of the xiphoid. All electrodes in one level being 
electrically connected, an alternating current of 0.8 
mA RMS and 60 kHz was passed through the current 
applying electrodes and impedance (R) was calcu-
lated using Ohm’s law (R = V / I; where V = meas-
ured voltage and I = strength of alternating current). 
All data were digitally stored and 20 consecutive 
heart cycles were averaged by means of our data ac-
quisition system, after which signal variables were 
manually assessed as described by Lababidi et al. 
(11). Finally, SV was calculated with the equation of  
 
 non-H H p 
Number 44 24  
Sex (f/m) 19/25 11/13 NS 
Age (years) 54 (2.9) 58 (3.5) NS 
Dry weight (kg) 63.4 (2.3) 68.4 (3.3) NS 
Diabetes Mellitus 2/44 4/24 NS 
Antihypertensive Drugs 25/44 18/24 NS 
History of HD (months) 58 (9.1) 40 (8.5) NS 
Figure 1. Electrode configuration for electrical impedance cardiography:  
c = current applying electrodes and v = voltage detecting electrodes. 
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Kubicek (12). Simultaneously with the impedance recordings, lead I of the ECG was re-
corded and mean arterial blood pressure (MAP) was measured every 10 minutes using a 
cuff sphygmomanometer. CO was calculated as stroke volume (SV) times heart rate 
(HR), and SVR as (MAP/CO) * 80, expressed as dynes/s/cm-5. To assess reproducibility, 
Mehlsen and colleagues tested 62 measurements of cardiac output in a range from 2.95 
to 10.16 l/min (mean 5.76 l/min) and the standard deviations were 0.33 l/min (the in-
ter-observer variation) and 0.12 l/min (intra-observer variation) (13). It was concluded 
that impedance cardiography is reliable in measuring changes in cardiac output and 
therefore suitable for repeated measurements as in our study.  Because aortic valvular 
pathology appeared to produce less reliable CO values (14), these patients were ex-
cluded from the present study. 
Blood volume monitoring 
An optical device (Critline®, In-Line Diagnostics, Riverdale (Utah), USA) was used in order 
to monitor variations in blood volume during HD continuously and non-invasively, as 
described by De Vries et al. (15). This method is based on the principle of infrared light 
propagation in whole blood. When monochromatous near infrared light is transmitted 
through blood, three processes occur: a part of the light will pass through the blood un-
impeded, another part will be absorbed by blood components, among which hemoglo-
bin is the most important, and a third part will be reflected by erythrocytes as a result 
of scattering (16,17). The amount of detected reflected light is directly proportional to 
the concentration of blood cells in whole blood. Because erythrocyte concentration is 
reciprocally related to blood volume, the variations in blood volume can easily be calcu-
lated using the data derived from the optical device. The measuring probe of this de-
vice, placed at the arterial side of the dialyzer, consists of a light-emitting diode and a 
light-detecting receiver. The calculation is performed by a small computer and shown 
graphically on a display. Blood samples were taken every hour for laboratory assess-
ment of erythrocyte concentration. Ultrafiltration was held constant during HD. Assum-
ing that changes in blood volume during HD only occur because of extracorporeal ul-
trafiltration and vascular refilling, blood volume will decrease when the ultrafiltration 
rate exceeds vascular refilling rate. 
 
Statistical analysis 
Differences between the two groups were analyzed by means of the unpaired Student’s 
t test, and between different time intervals within one group by means of the repeated 
measures analysis of variance. The relationship between different variables was evalu-
ated using linear regression analysis. Interdependency between variables was tested by 
multiple regression analysis. Chi square tests were performed to express the difference 
in the distribution of cardiovascular medication and sex. P values < 0.05 were consid-
ered significant. 
 
RESULTS 
 
In 24 (13 males; 11 females) out of the 68 patients a symptomatic hypotensive episode 
occurred, requiring temporarily UF cessation, and infusion of an isotonic saline or a hy-
perosmotic gelatin solution (Gelofusin®) if necessary. The distribution of cardiovascular 
medication in the hypotensive and the stable group was not significantly different (p > 
0.1; Table 1). The hypotensive episodes occurred on average 198 minutes (SEM ± 9 min) 
after the start of HD, and were compared to the t=180 min. measurement in the non-H 
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group. No significant differences were observed between the t=180 and the t=240 min. 
measurements in the non-H group, except for the decrease in BV (t=180: -6.5 ± 0.8% vs. 
t=240: -8.7 ± 0.9%, p < 0.001). During these hypotensive episodes MAP decreased from 
96 to 66 mmHg (SEM ± 2.6) in the H group, whereas at the corresponding moment in 
the non-complicated dialysis sessions MAP amounted to 96 mmHg (SEM ± 2.2). In Table 
2 the changes of the hemodynamic variables in the two groups are provided. All data 
analyses with mean arterial pressures were also performed with systolic and diastolic 
blood pressures and did not change any results. Multiple regression analysis was per-
formed to test the dependency between the change in MAP (dMAP) and the changes in 
Table 2. Changes in hemodynamic variables in the hemodynamically stable (non-H) and the hy-
potension-prone (H) patients from the start of treatment until the average time of hypotension 
(or the similar moment in the non-H group). 
 
All values are expressed as their mean (SEM). 
 non-H H P-value 
Number 44 24  
dMAP (%) -4.8 (1.6) -30.5 (3.0) <0.001 
dSVR (%) 6.2 (3.5) -17.9 (4.4) <0.001 
dCO (%) -7.3 (2.7) -11.8 (4.2) 0.35 
dSV (%) -10.8 (3.0) -21.1 (4.1) 0.04 
dHR (%) 5.7 (2.5) 13.1 (2.9) 0.07 
dBV (%) -6.5 (0.8) -9.4 (1.2) 0.04 
Table 3. Absolute values of hemodynamic variables at the start, at the hypotensive episode (H) 
or corresponding moment (non-H), and at the end of dialysis in hypotensive (H, n = 24) and non-
hypotensive (non-H, n = 44) patients. 
 
All values are expressed as their mean (SEM). §: dynes/s/cm-5; * P < 0.001 within group 
(ANOVA); # P < 0.05 within group (ANOVA);1 P < 0.001 compared to non-H;  2 P < 0.05 compared 
to non-H. 
  non-H   H  
 start 3 h. end start H end 
MAP (mmHg) 102 (2.2) 96 (2.2) 97 (2.4)* 96 (2.6) 66 (2.6)1 75 (3.0)1,* 
CO (l) 4.6 (0.3) 4.2 (0.3) 4.0 (0.3)* 3.9 (0.4) 3.4 (0.3) 3.2 (0.3)2,# 
SV (ml) 62.9 (3.8) 56.1 (3.7) 52.9 (3.5)* 54.5 (5.6) 41.6 (4.1)2 40.5 (3.8)
2,* 
HR (bpm) 73 (1.6) 76 (1.6) 78 (1.9)# 75 (2.7) 84 (3.1)2 84 (3.0)* 
SVR (§) 2152 (164) 2282 (213) 2347 (208) 2373 (222) 1907 (206) 2187 (235)
* 
Ht (%) 33.5 (0.6) 35.7 (0.7) 36.6 (0.7)* 33.9 (0.9) 37.6 (1.0) 37.2 (1.0)* 
UF (l) 0 2.1 (0.1) 2.7 (0.1) 0 2.8 (0.2)1 3.1 (0.2)2 
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Figure 2. Systemic vascular resis-
tance index (mean ± SEM) during 
hemodialysis. Note that t = 4 in 
group H is after intervention. 
Open bars = H, closed bars = non-
H, * = P < 0.001 compared to t = 
0. 
Figure 3. Correlation between 
change in systemic vascular resis-
tance (dSVR) and change in mean 
arterial pressure (dMAP) from the 
start of dialysis until the moment 
of hypotension or the similar mo-
ment in the non-H group. • = non-
Hypotensive group; ∆ = Hypoten-
sive group. 
Figure 4. Correlation between 
change in BV (dBV) and change in 
mean arterial pressure (dMAP) 
from the start of dialysis until the 
moment of hypotension or the 
similar moment in the non-H 
group. • = non-Hypotensive group; 
∆ = Hypotensive group. 
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hemodynamic factors determining MAP, such as dSVR, dSV, dHR and dBV. It revealed an 
association between dSVR and dMAP in both the H group (ß = 1.23, p < 0.001) and the 
non-H group (ß = 1.52, p < 0.001). 
The most significant difference between the two groups was a change in systemic vas-
cular resistance from the start of dialysis until the moment of hypotension (H -17.9 ± 
4.4% vs. non-H +6.2 ± 3.5%, p < 0.001). Figure 2 shows the change in SVR occurring 
from hour to hour in both groups. The Pearson’s correlation between changes in SVR 
and MAP (Figure 3) was highly significant in the whole group (r = 0.61, p < 0.001), as 
well as in the H group (r = 0.55, p = 0.006) and the non-H group (r = 0.41, p = 0.005). 
The UF volume at the moment of hypotension (see Table 3) was higher in the hypoten-
sion-prone patients (2.8 l) compared to the UF volume at the corresponding moment in 
hypotension-resistant patients (2.1 l, p < 0.001), which corresponded with a signifi-
cantly steeper fall in BV (-9.4% in H vs. -6.5% in non-H, P = 0.04), suggesting a more pro-
nounced hypovolemia in hypotensive patients. However, changes in BV did not correlate 
with changes in MAP neither in the whole group (r = 0.12, p = 0.31) (Figure 4), nor in 
one of the subgroups (H: r = 0.18, p = 0.39; non-H: r = -0.29, p = 0.06). Multiple regres-
sion analysis revealed no significant dependency between dMAP and dBV, neither be-
tween dSVR and dBV. BV variation recorded in 68 dialysis sessions by means of the opti-
cal measurement of hematocrit changes corresponded very well with changes in labora-
tory erythrocyte counts ( r = 0.90, p < 0.001) and hematocrit ( r = 0.85, p < 0.001) of 
control blood samples drawn hourly from the arterial blood line. Hematocrit was similar 
in the two groups (Table 3). 
SV decreased more severely in the hypotensive group (H -21.1% vs. non-H -10.8%, p = 
0.04). However, heart rate tended to increase more in hypotension-prone patients (H 
+13.1% vs. non-H +5.7%, P = 0.07), resulting in a similar decrease in CO in both groups. 
No correlation was found between changes in CO and changes in MAP (H: r = 0.20, p = 
0.35; non-H: r = 0.14, p = 0.37). 
 
DISCUSSION 
 
The origin of hypotension in dialysis patients is multifactorial. Some factors are patient-
specific such as comorbidity of the vascular system, heart disease, autonomic neuropa-
thy, anemia and plasma refill capacity, and some are dialysis-specific such as dialysate 
temperature, dialysate sodium and dialysate buffer. Ultrafiltration rate, type of mem-
brane and eating during dialysis also are of influence. Hypovolemia is generally thought 
to play an important role in intradialytic hypotension since hypotension only rarely oc-
curs without hypovolemia. However, with adequate compensation of the cardiovascular 
system moderate hypovolemia should not progress to symptomatic hypotension. This 
suggests that in hypotensive episodes the compensatory response to hypovolemia is 
inadequate. Important compensatory factors are CO and SVR. We found intradialytic hy-
potensions to occur during a deep fall in SVR with a concomitant increase in heart rate. 
Although less pronounced, CO and BV in the hypotensive group also decreased more 
than in the stable group. Factors influencing cardiac compensation are intrinsic cardiac 
characteristics, preload, and afterload. 
Concerning the intrinsic cardiac factors, decreased contractility due to pre-existent car-
diac morbidity and, even more important, decreased left ventricular compliance as a re-
sult of increased heart mass, are risk factors for hypotension in dialysis patients. Left 
ventricular hypertrophy (LVH) is present in more than 60% of ESRD patients (18).  
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Concerning the preload, several mechanisms can interfere with adequate preservation 
of venous return. First, possible structural abnormalities of the venous wall have been 
mentioned by Kooman et al. in hypertensive HD patients (19). The hereby-reduced com-
pliance impairs plasma refill by altering capillary Starling equilibrium. Second, a fall in 
SVR, as is observed during dialysis, can reduce the venous return by interference with 
the DeJager-Krogh phenomenon, acting as follows (20). Normally, under conditions of 
increased SVR the flow of blood into a capillary bed will be diminished and distending 
pressure will thus be reduced. Consequently, because of passive recoil of the vascular 
bed, blood sequestered in the venous bed will be mobilized. As a result, venous return 
will be stimulated while cardiac afterload has increased, mitigating the fall in CO. In 
case of a decrease in SVR active venoconstriction reduces and venous return will be di-
minished (21). 
Concerning the afterload of the heart, SVR is supposed to increase under conditions of 
hypovolemia in order to maintain adequate blood pressure. From our results it has be-
come clear that at the moment of hypotension the SVR has fallen dramatically. The dif-
ferences between H and non-H in dCO and dBV can be explained as follows. A fall in SVR 
at the moment of hypotension counteracts the above-mentioned DeJager-Krogh phe-
nomenon. Therefore, venous return will fall more severely and, consequently, CO will 
show a more pronounced decrease. Furthermore, when SVR decreases, capillary inflow 
will increase resulting in a rise in intracapillary pressure. This impairs plasma refill from 
the interstitium and thus leads to a greater decline in BV. 
Another explanation for the sudden decrease in SVR could be an imbalance between 
various vaso-active substances. Normally, to maintain an adequate blood pressure, an 
UF-induced decrease in BV will be counteracted by a rise in vasoconstrictive agents - 
such as (nor)adrenaline, renine and vasopressin - and/or a decrease in vasodilating 
agents such as nitric oxide (NO) and calcitonin-gene related peptide (C-GRP). In the past 
decade, several reports have been published with regard to the vaso-active response to 
hemodynamic changes. However, their results remain conflicting, although the role of 
NO as an inappropriate vasodilatator gains increasingly more evidence (6,22,23). The 
mechanism driving this NO release remains to be elucidated. 
Santoro and coworkers distinguished a bradycardiac and a tachycardiac collapse during 
HD: the bradycardiac type presenting with a decrease in heart rate and an increase in 
stroke volume during the hypotensive episode, and the tachycardiac type with an eleva-
tion in heart rate and a reduction in stroke volume (24). Bradycardia is believed to occur 
due to extreme hypovolemia inducing a cardioprotective reflex, the Bezold-Jarisch re-
flex. This type of hypotension is therefore due to underhydration and can be reversed 
by adjusting the patient’s dry weight. In our population no bradycardiac hypotensions 
occurred. Zoccali et al. recently stated that bradycardiac hypotension is the result of a 
more severe degree of volume depletion and that tachycardiac hypotensions predomi-
nate by far the bradycardiac hypotensions (25). As a result of increasing age and comor-
bidity of the dialysis population over the years, the origin of intradialytic complications 
such as hypotension becomes more complex by failure of multiple compensation 
mechanisms. The relatively ‘simple’ hypovolemic hypotension is observed less fre-
quently because of adequate intervention and prevention, and becomes increasingly 
overruled by hypotensions of more complex origin. The challenge for the future will be 
to identify the specific underlying problem(s) in the individual patient and to use this 
knowledge for individual dialysis policy. Although several hypotheses have been raised 
over the years, we want to add strength to the suggestion that a fall in SVR plays a cru-
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cial role in the occurrence of intradialytic hypotension, at least in a substantial group of 
patients. Further research will be necessary to disentangle the cause of this unfavorable 
fall in SVR. 
We conclude that a failure to increase SVR as a response to ultrafiltration-induced hypo-
volemia is the most prominent cause of intradialytic hypotension. The UF-induced de-
crease in BV lowers blood pressure in all dialysis patients, but the degree of hypo-
volemia seems not to play a key role in the origin of acute, intradialytic hypotensive epi-
sodes. Since all mentioned variables could be determined non-invasively, monitoring 
during hemodialysis offers the possibility to identify the site of hemodynamic failure in 
an individual patient and thus enables proper interventions and possible prevention of 
dialysis-induced hypotension. 
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ABSTRACT 
 
Background. Intradialytic hypotension (IDH) in hemodialysis patients is a multifactorial 
problem. This suggests a possible classification into different types of hypotension, 
which could be helpful to identify different pathways leading to this complication and, 
consequently, to apply appropriate preventive strategies. 
Methods. During hemodialysis, cardiac performance was monitored in 23 hypotensive 
hemodialysis patients by means of electrical impedance cardiography. Variation in 
blood volume was measured by means of an on-line optical probe, and hydration state 
by means of body impedance analysis. Based on intradialytic hemodynamic parameters 
an attempt was made to differentiate in the origin of IDH between the hypotensive pa-
tients. 
Results. Based on the most pronounced decrease in either cardiac stroke volume or sys-
temic vascular resistance on the moment of IDH, two groups could be differentiated. 
Twelve patients showed a predominant fall in systemic vascular resistance (SVR-H), 
whereas 11 patients showed a more pronounced decrease in cardiac output, more spe-
cifically caused by decline in cardiac stroke volume (SV-H; -38.7 ± 3.0% vs. SVR-H: -8.0 ± 
4.8%, p < 0.001). The decrease in blood volume was not significantly different between 
the groups (-10.9 ± 1.6% vs. SVR-H: -7.4 ± 1.8%, p = 0.15). Also, no correlation was ob-
served between decrease in blood volume and the drop in mean arterial pressure 
(dMAP). The correlations between dSV and dMAP (r = 0.66, p = 0.03) and change in car-
diac output (dCO) and dMAP (r = 0.83, p = 0.002) were significant.  
In the SVR-H group, the hypotension was due to a steep fall in systemic vascular resis-
tance, beginning already early in HD (-32.6 ± 4.6% vs. SV-H +2.0 ± 3.1%, p<0.001), inde-
pendent of vascular refill and cardiac function. Despite a larger UF volume, the SVR-H 
group demonstrated similar changes in BV and CO as the non-H group. 
Conclusion. Based on different hemodynamic response patterns, IDH seems to be due 
to a cardiac filling failure triggered by mild underhydration leading to hypovolemia in 
one subgroup, while in another subgroup  a fall in SVR, independent of adequate vascu-
lar refilling and cardiac function, is the cause of IDH. Different preventive strategies 
could be proposed for the different subgroups. Thus, a classification in stoke volume 
dependent and systemic vascular resistance dependent is possible within hypotension 
prone hemodialysis patients. 
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INTRODUCTION 
 
The dialysis population has changed over the years. At present, patients on hemodialy-
sis become increasingly older and have more comorbidity, especially of the cardiovascu-
lar system. Despite technical improvements, intradialytic hypotension (IDH) continues to 
be a major problem in hemodialysis treatment today. Nowadays the ‘classical’ hypoten-
sion, due to severe hypovolemia induced by an inappropriately assessed dry weight or a 
too vigorous ultrafiltration (UF) rate for the individual patient, is less frequently seen. 
This can be attributed to the introduction of on-line blood volume monitors, as well as 
to improved and extended tools to determine more accurately a patient’s dry weight.  
Several hypotheses concerning the origin of IDH have been raised over the years. Most 
of them focus on a single part of the hemodynamic regulating system. Some authors 
suggested that the reduced capacity of the heart to increase contractility plays an im-
portant role (1). Others blamed a sudden fall in systemic vascular resistance (SVR) as the 
predominant failing compensating mechanism to the decrease in mean arterial pressure 
(MAP) (2). In an earlier study, we reported the importance of the role of the systemic 
vascular resistance in the total group of hypotension prone patients (3). Recently, these 
findings were confirmed in a study using lower body negative pressure (LBNP). The lack 
of increase in SVR was more pronounced during HD than during LBNP, with cardiac fill-
ing being reduced in both situations. Concluded was that hypotension resulted from the 
inability to adequately increase arteriolar tone and a reduction in left ventricular func-
tion, without a significant role for relative blood volume (4). The cause of impaired vas-
cular resistance responsiveness has been sought in sympathetic inhibition (5,6), vasoac-
tive substances such as nitric oxide (2,7) and adenosine (8), as well as increase in body 
temperature during HD (9).  Various preventive strategies have been proposed, such as 
cool dialysate (10), sodium profiling (11-13), and sympathetic agonists such as mi-
dodrine (14,15). However, these strategies have been applied to all hypotension prone 
dialysis patients, regardless of their individual underlying causative mechanisms. Mod-
ern patient care tends towards tailor-made, individual policies. Regarding the long his-
tory of studies on intradialytic hypotension, individualized care will likely be the future 
for hypotension prone dialysis patients. Some technical developments have reached the 
goal of modification of hemodialysis strategies by adjusting sodium content of the 
dialysate in response to alterations in blood volume (16).  
It is clear that no simple, uniform solution can be found for such a multifactorial prob-
lem as IDH. Therefore, it is important to classify the different types of IDH. Previous 
classifications, such as the division into the bradycardiac and tachycardiac types, have 
proven their usefulness (17). The bradycardiac type was recognized to be due to a sym-
patho-inhibitory, cardioprotective reflex (the Bezold-Jarisch reflex), induced under con-
ditions of extreme hypovolemia (18). These patients were likely to be underhydrated 
and the simple solution should be to adjust their dry weight (19).  
Current techniques, such as electrical impedance cardiography, provide the opportunity 
to monitor intradialytic hemodynamics. Although not widespread used, it could be of 
great value to the physician to identify the underlying problem of the unstable patient. 
We studied our population of dialysis patients. The patients suffering from intradialytic 
hypotension were identified and subsequently subdivided based on the primary cause 
of their hypotension, being either due to a drop in stroke volume or due to a fall in sys-
temic vascular resistance. Both groups were then compared to each other as well as to 
the stable control group (non-H). The aim of the study was to establish a new classifica-
tion of IDH, based on the core blood pressure determinants. 
Chapter 3 
 
34 
SUBJECTS AND METHODS 
 
Subjects 
Sixty-seven patients on chronic intermittent hemodialysis were monitored during a stan-
dard hemodialysis session. Patients with documented heart failure were excluded from 
the study. The patients experiencing a hypotensive episode during HD were analyzed 
with respect to their hemodynamic response prior to the blood pressure decline. Spe-
cific emphasis was placed on the type of response, i.e. predominantly cardiac or vascu-
lar resistance. Stable patients were used as the control group. A hypotensive episode 
during dialysis was defined as a symptomatic decrease in systolic blood pressure of 30 
mmHg or more. All patients were dialyzed three times per week for 3-5 hours with bio-
compatible polysulfone membranes, using bicarbonate as buffer and heparin as antico-
agulant. Blood flow varied from 200 to 300 ml/min, whereas the dialysate flow was 500 
ml/min and the dialysate sodium concentration 141 mmol/L. Dry body weight was de-
termined individually by the attending physician on clinical grounds such as blood pres-
sure, central venous pressure, and the absence of peripheral and/or pulmonary edema. 
Ultrafiltration volume was based on the difference between pre-dialysis and desired dry 
weight. Antihypertensive medication was withheld on the day of dialysis. All patients 
gave their informed consent. 
 
Hemodynamic variables 
Blood pressure was recorded using an automatic cuff sphygmomanometer every 30 
minutes and on occurrence of symptoms of hypotension, such as dizziness, muscle 
cramps, perspiration, or frequent yawning. Variation in blood volume (BV) was moni-
tored by means of an on-line optical device (Critline®, In-Line Diagnostics, Riverdale 
(Utah), USA). This procedure is based on the non-invasive and continuous measurement 
of changes in hematocrit, inversely correlated to blood volume variation (20). Labora-
tory erythrocyte counts were performed on blood samples drawn hourly from the arte-
rial line as control determinations of the BV monitoring. SV recordings were performed 
hourly utilising electrical impedance cardiography (IPG-104 impedance Mini-Lab by RJL 
Systems, Detroit, USA, and Equip Medikey, Gouda, The Netherlands), a valid, non-
invasive, bed-side method to determine SV based on intrathoracical changes in electrical 
resistance due to heart pumping (21-24). Simultaneous ECG recordings provided heart 
rate (HR), and CO was calculated as SV * HR. In addition, SVR was obtained using the 
Table 1. Characteristics of the two hypotension groups and the control group (non-H). 
 
All values are expressed as their mean ± SEM. HD = hemodialysis. 
 non-H SVR-H SV-H 
Number 44 12 11 
Sex (f:m) 19:25 6:6 4:7 
Age (years) 54 ± 3 62 ± 4 56 ± 5 
Dry weight (kg) 63 ± 2 69 ± 3 69 ± 6 
Antihypertensive Drugs 25/44 9/12 8/11 
History of HD (months) 58 ± 9 27 ± 9 46 ± 13 
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formula SVR = MAP / CO * 80, expressed as dynes/s/cm-5. Total body water (TBW) and 
extracellular water (ECW) were assessed at the start and the end of treatment by means 
of the whole body impedance method according to Lukaski (25).  
 
Statistical analysis 
Differences between several groups were analyzed by means of analysis of variance, af-
ter which differences between two specific groups were analyzed using the unpaired 
Student’s t test. The relationship between different variables was evaluated using linear 
regression analysis. Interdependency between variables was tested by multiple regres-
sion analysis. P values < 0.05 were considered significant. 
 
RESULTS 
 
Hypotensive episodes occurred in 23 of 67 HD sessions (34%). Hemodynamic responses 
were analyzed and the group of hypotensive patients could be subdivided based on the 
most pronounced decrease in either stroke volume or systemic vascular resistance. 
Thus, three groups could be formed: a stable group (non-H, n = 44), a group with pre-
dominant decline in systemic vascular resistance (SVR-H, n = 12), and a group with a 
predominant decrease in stroke volume (SV-H, n = 11). Patient characteristics of the 
three groups are given in Table 1. The hypotension episodes occurred on average at 
196 ± 47 minutes after initiation of HD in the SV-H group and at 206 ± 36 min. in the 
SVR-H group (see Figure 1). The hemodynamic variables were compared with the data 
measured at 180 min. in the stable control group. In the SV-H group the decrease in 
blood volume was significantly higher than in non-H, also after correction for a higher 
UF volume (see Tables 2 & 3). No significant differences were observed between the 
three groups in tissue hydration status (see Table 2). SV fell highly significant in the SV-
H group (-38.7 ± 3.0%) but only slightly in the SVR-H (-8.0 ± 4.8%) and the non-H (-10.8 
± 3.0%) groups (see Figure 2). Multiple regression analysis in the SV-H group revealed a 
predominant relationship between dCO and dMAP (ß = 1.07, p < 0.001). With Pearson’s 
correlation coefficient, the decrease in SV correlated moderately with the decrease in 
MAP (r = 0.66, p = 0.03), but dCO showed a strongly significant correlation with dMAP (r 
= 0.83, p = 0.002). No correlation was found between dSVR and dMAP. Remarkably, no 
correlation was found between dBV and dMAP either. 
In the SVR-H group, the cumulative UF volume at the moment of hypotension was simi-
lar to the SV-H group but significantly larger than in the stable patients (Table 2). How-
ever, dBV as well as dBV/UF were similar to the non-H group, indicating adequate vascu-
lar refill. The stability of SV and CO was at least as good as in the stable group (Table 
3). Besides the dMAP, the only variable significantly differing from non-H was the dSVR, 
which demonstrated a steep fall during the entire dialysis. As can be read from Figure 3, 
already after the first hour dSVR had declined more than in the non-H group (-8.8 ± 7.2% 
vs. +3.3 ± 2.6%, p = 0.06), and in the SV-H group (+13.4 ± 6.9, p = 0.04). This differ-
ence progressed in the subsequent hours until a measured maximum dSVR at the mo-
ment of hypotension, reaching -32.6 ± 4.6% versus +2.0 ± 3.1% in the SV-H group (p < 
0.001), and +6.2 ± 3.5% in the non-H group (p < 0.001). dSVR showed a strong correla-
tion with dMAP with multiple regression analysis (ß = 1.15, p < 0.001), as well as with 
Pearson’s coefficient (r = 0.83, p = 0.001). The dMAP in the SVR-H group showed no cor-
relation with either dSV or dCO. 
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DISCUSSION 
 
In the present study an attempt was made to classify a group of hypotensive patients 
based on the main hemodynamic variables determining blood pressure, namely SV and 
SVR. In doing so, we observed that despite the larger UF volume in both hypotensive 
groups compared to stable patients, only the SV-H group demonstrated a significantly 
greater dBV than the non-H group. This suggests a cardiac filling problem. However, 
dBV appeared not to be a statistically significant determinant of blood pressure preser-
vation, while dSV was. Adequate tachycardia could not preserve CO. For the SV-H group, 
it can be concluded that cardiac compensation to subclinical hypovolemia failed. Man-
agement of this type of IDH might be a slight adjustment of the patient’s dry weight or 
cardiotonic medication. 
In the SVR-H group, refilling and cardiac compensation were adequate, but SVR de-
creased inappropriately. The cause of this fall could not be clarified from our data. Be-
cause of the observed tachycardia and the absence of underhydration, the SVR drop 
could not be due to the Bezold-Jarisch reflex, a strong sympatho-inhibitory reflex origi-
nating from a deformed ventricle wall under conditions of severe hypovolemia and re-
sulting in a strong bradycardia and peripheral vasodilatation. The presently most likely 
hypotheses to explain this drop in SVR are either a decrease in sympathetic tonus dur-
ing HD (5,26), and/or NO release (2). 
In conclusion, in the SV-dependent hypotension, mild hypovolemia seems to trigger a 
profound decrease in SV, probably by impaired cardiac filling, which might be prevented 
by dry weight adjustment. In the SVR-dependent hypotension, severe inappropriate 
vasodilatation is the cause of IDH. Classification of intradialytic hypotension by means 
of non-invasive hemodynamic monitoring enables a more specific approach of this com-
plex, multifactorial problem, and increases insight in the different pathophysiological 
pathways leading to it.  
 
Table 2. Absolute values of hemodynamic variables at the start and at the hypotensive episode 
(H) or at the corresponding moment (3 h.) in the two hypotensive groups (SVR-H and SV-H) and 
in the control group (non-H). 
 
All values are expressed as their mean ± SEM. § = dynes/s/cm-5; $  = at the end of HD;  
* = P < 0.001 compared to non-H;  # = P < 0.05 compared to non-H.  
 non-H  SVR-H  SV-H  
 start 3 h. start H start H 
MAP (mmHg) 102 ± 2.2 96 ± 2.2 95 ± 3 64 ± 3* 97 ± 3 70 ± 4* 
CO (l) 4.6 ± 0.3 4.2 ± 0.3 3.6 ± 0.4 3.7 ± 0.4 4.5 ± 0.7 3.1 ± 0.5 
SV (ml) 62.9 ± 3.8 56.1 ± 3.7 51 ± 6 46 ± 6 61 ± 10 37 ± 6# 
HR (bpm) 73 ± 1.6 76 ± 1.6 75 ± 5 84 ± 5 75 ± 3 87 ± 3# 
SVR (§) 2152 ±164 2282 ±213 2365 ±241 1618 ±247 2157 ±321 2178 ±332 
Ht (%) 33.5 ± 0.6 35.7 ± 0.7 33.9 ± 1.4 36.9 ± 1.5 35.3 ± 1.1 39.7 ± 1.2* 
UF (l) 0 2.1 ± 0.1 0 2.8 ± 0.3# 0 2.9 ± 0.3# 
ECW/TBW (%) 50.9 ± 2.0 48.4 ± 2.0
$ 53.7 ± 3.4 48.5 ± 2.0$ 46.3 ± 2.0 44.0 ± 2.0$ 
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Table 3. Changes in hemodynamic variables in the control group (non-H) and the two hypoten-
sion groups (SVR-H and SV-H) from the start of treatment until the average time of hypotension 
(or the similar moment in the non-H group). 
 
All values are expressed as their mean ± SEM. * = P < 0.001 compared to control group;  
# = P < 0.05 compared to control group. 1 = P < 0.001 between SVR-H and SV-H. 
Figure 1. The change in blood pressure during dialysis in the two hypotensive groups (SV-H and 
SVR-H) and the stable controls (non-H). * = p < 0.001 compared to non-H. 
 Non-H SVR-H SV-H 
dMAP (%) -4.8 ± 1.6 -31.9 ± 4.1* -28.2 ± 3.6* 
dSVR (%) +6.2 ± 3.5 -32.6 ± 4.6* +2.0 ± 3.11 
dSV (%) -10.8 ± 3.0 -8.0 ± 4.8 -38.7 ± 3.0*,1 
dHR (%) +5.7 ± 2.5 +12.9 ± 4.2 +16.0 ± 4.0 
dCO (%) -7.3 ± 2.7 +2.6 ± 4.4 -29.2 ± 3.9*,1 
dBV (%) -6.5 ± 0.8 -7.4 ± 1.8 -10.9 ± # 
dBV/UF (%/l) -2.7 ± 0.3 -2.5 ± 0.7 -4.0 ± 0.5# 
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Figure 2. The change in stroke volume during dialysis in the two hypotensive groups (SV-H and 
SVR-H) and the stable controls (non-H). * = p < 0.001 compared to SVR-H and non-H. 
Figure 3. The change in systemic vascular resistance during dialysis in the two hypotensive 
groups  and the stable controls (non-H). * = p < 0.001 compared to SV-H and non-H. 
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ABSTRACT 
 
Background. Intradialytic hypotension is of multifactorial origin, several strategies be-
ing developed to prevent it. In order to customize hemodialysis care, it is important to 
classify different types of intradialytic hypotension. In a previous study we classified hy-
potension prone hemodialysis patients into two groups based on a fall in systemic vas-
cular resistance or a fall in stroke volume. In the present study repeated measurements 
of intradialytic hemodynamics were performed in hypotension prone patients, aimed at 
demonstrating reproducibility of category of intradialytic hypotension.  
Methods. Ten hypotension prone hemodialysis patients were monitored hemodynami-
cally during five dialysis sessions. Noninvasive bedside Electrical Impedance Cardiogra-
phy provided hemodynamic variables such as stroke volume, cardiac output and sys-
temic vascular resistance. 
Results. In 36 out of 50 sessions a hypotensive episode occurred. In 7 out of 10 pa-
tients the hemodynamic response pattern was reproducible, whereas in the remaining 
three patients the pattern was unpredictable.  
Conclusion. Hemodynamic monitoring during hemodialysis provides important infor-
mation about type of intradialytic hypotension. In the majority of dialysis patients the 
origin of hypotension is reproducible. This enables application of specific individualized 
therapy. 
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INTRODUCTION 
 
Intradialytic hypotension (IDH) occurs when normal compensatory mechanisms cannot 
keep up with the removal of fluid and solutes in a short time span. The main factor is 
the reduction of blood volume, necessitating adequate capillary refill to maintain blood 
pressure. Normal compensatory mechanisms include increase in heart frequency and 
contractility to maintain cardiac output during hypovolemia. Furthermore, arteriolar con-
striction increases afterload and venoconstriction mobilizes the venous blood pool in 
order to increase venous return.  
Failure of either of these mechanisms may lead to intradialytic hypotension, leading to 
diminished dialysis efficacy and discomfort for the patient. 
Diminished cardiac reserve leads to a poor response to hypovolemia  (1). Decreased sys-
temic vascular resistance plays an important role in inducing hypotension (2), its possi-
ble mechanisms being  a paradoxal withdrawal of sympathetic tone  (3), local release of 
vaso-active substances as adenosine or nitric oxide, or a decreased autonomic response  
(4-6). 
Finally, impaired venous tone leads to diminished capillary refill, thereby reducing ve-
nous return, resulting in a diminished cardiac filling. Ultimately, a fall in blood pressure 
will occur  (7). 
Several strategies have been proposed to support compensatory mechanisms. There are 
strategies to enhance capillary refill by reducing osmotic shifts such as balanced so-
dium profiling  (8). Furthermore, lower temperature dialysis improves venous tone and 
thereby venous return (9-11). Some authors reported beneficial effects of sympathetic 
agonists such as midodrine to counteract sympathetic withdrawal (12). 
However, all preventive strategies may have side effects. Sodium profiling, especially 
when administered incorrectly, may cause hypertension by sodium loading. Cool dialys-
ate dialysis and sympathetic agents may be uncomfortable for the dialysis patient. 
This raises a need for determination of individually effective preventive strategies, 
based on the pathophysiologic mechanism leading to hypotension. Electrical impedance 
cardiography provides a tool for noninvasive monitoring of intradialytic hemodynamics 
(13-16)  and might therefore be helpful to reach this goal. 
In a previous study we could classify hypotension prone patients into two catego-
ries, based on a predominant decrease in either systemic vascular resistance (SVR) or 
stroke volume (SV) (submitted data). The present study is aimed at investigating 
whether these different pathophysiologic pathways are reproducible within hypotension 
prone hemodialysis patients, by means of monitoring several dialysis sessions.  
 
PATIENTS AND METHODS 
 
Patients 
Ten hypotension prone patients were studied during 5 hemodialysis sessions. Hypoten-
sion prone was defined as having had more than three hypotensive episodes during the 
ten prior consecutive dialysis sessions. A hypotensive episode during dialysis was de-
fined as a decrease in systolic blood pressure of >30 mmHg or an absolute systolic 
blood pressure of < 90 mmHg during dialysis, accompanied by hypotensive symptoms 
such as dizziness, frequent yawning or perspiration. Patient characteristics are given in 
Table 1.  
No interventions such as change in dry weight occurred during the study period. Indi-
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vidual hemodynamic responses to simultaneous ultrafiltration and solute dialysis were 
monitored. All patients were dialyzed three times per week for 4 hours with biocompati-
ble polysulfone membranes, using bicarbonate as buffer and heparin as anticoagulant. 
Blood flow was 250 ml/min, whereas the dialysate flow was 500 ml/min and the dialys-
ate sodium concentration 140 mmol/L. Ultrafiltration volume was based on the differ-
ence between pre-dialysis and desired dry weight. All patients gave their informed con-
sent. 
Methods 
Blood pressure was recorded using an automatic cuff sphygmomanometer every 30 
minutes and on occurrence of symptoms of hypotension, such as dizziness, muscle 
cramps, perspiration, or frequent yawning. Blood volume variation was monitored by 
means of an on-line optical device (Critline®, In-Line Diagnostics, Riverdale (Utah), USA), 
based on the non-invasive and continuous measurement of changes in hematocrit, in-
versely correlated to blood volume (BV) variation  (17,18). Laboratory erythrocyte counts 
were performed on blood samples drawn hourly from the arterial line as control deter-
minations of the BV monitoring. Stroke volume (SV) recordings were performed hourly 
utilising electrical impedance cardiography (IPG-104 impedance Mini-Lab by RJL Sys-
tems, Detroit, USA, and Equip Medikey, Gouda, The Netherlands), a valid, non-invasive, 
bed-side method to determine SV based on intrathoracical changes in electrical resis-
tance due to heart pumping (13,14,19,20). Simultaneous ECG recordings provided heart 
rate (HR), and cardiac output (CO) was calculated as SV * HR. In addition, systemic vas-
cular resistance (SVR) was obtained using the formula SVR = (MAP / CO) * 80, expressed 
as dynes/s/cm-5 where MAP is mean arterial pressure (mmHg). 
 
Statistical analysis 
The patterns of hemodynamic response were shown in a descriptive manner. Differ-
ences between groups were analysed by means of unpaired Students’ T-tests. Correla-
tion coefficients were calculated according to Pearson. 
Table 1. Patient characteristics 
 
Patient Age (yrs) Sex Duration of 
HD (months) 
Dry weight 
(kg) 
Antihypertensive 
drugs (no.) 
A 37 M 72 57.5 4 
B 70 F 12 46.5 3 
C 51 M 30 111.5 1 
D 57 F 125 54 0 
E 60 F 66 72 1 
F 78 M 8 79.5 0 
G 31 M 31 57.5 2 
H 40 F 5 75 1 
I 67 M 40 81.5 0 
J 57 M 14 125 4 
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RESULTS 
 
In 50 hemodialysis sessions in 10 hypotension prone patients, 36 dialysis-induced hy-
potensions requiring intervention occurred (72%). 
27 of 36 IDH episodes could be attributed to a predominant decrease in either SV 
(n=18) or SVR (n=9). The remaining 9 hypotensions were a combination of both. 
In the group of hypotensive dialysis sessions due to a decrease in SV (SV-H group), the 
only factor significantly correlated to MAP was SV (r = 0.78, p = 0.04). SVR did not influ-
ence MAP in that group. In the group of hypotensive sessions due to a fall in SVR (SVR-H 
group), however, SVR was the only correlated determinant of MAP (r = 0.73, p = 0.05), 
whereas there was no significant influence of SV. Interestingly, in the combination-
group there also was a significant role for SVR (r = 0.78, p = 0.01), whereas MAP did not 
correlate with SV (r = 0.47, NS), or with BV (r = 0.18, NS). The influence of BV on MAP 
was limited as there was no significant correlation in any subpopulation between BV and 
MAP or between BV and SV. 
A recognisable pattern was observed in 6 out of 10 patients, as is shown in Table 2. 
Four patients (A,B,D,F) became repeatedly hypotensive due to a predominant fall in 
stroke volume (SV) despite peripheral vasoconstriction, shown as an increase in SVR. 
The hemodynamic response of IDH characterised by a decrease in SV without an ade-
quate SVR increase is shown in Figure 1. Two patients (G,H) showed a pattern of de-
crease in SVR over several hypotensive episodes with only minimal decrease or even in-
crease in SV, except once (H1). Figure 2 displays an example of such a hemodynamic 
response. One patient (C) showed during 5 hemodialysis sessions only one hypotensive 
episode due to a diminished SV with only minimal SVR increase, whereas in the four sta-
ble sessions SVR response was adequate. 
However, 3 patients (E,I,J) failed to show a recognisable pattern, with absence of cardiac 
reserve capacity and absence of adequate vascular response. 
Measured by clinical behaviour and expressed in hemodynamic response, reproducibil-
ity was strong in 7 out of 10 patients.   
 
DISCUSSION 
 
Cardiovascular disease is the leading cause of morbidity and mortality in ESRD patients 
(21,22). Factors contributing to cardiovascular dysfunction are various (23,24). Pre-
existing diseases as diabetes mellitus are playing an important role (25), as well as di-
minished autonomic function in uremia  (26). IDH has been shown to increase mortality 
as an independent factor (27). Insight in individual hemodynamic response patterns pro-
vides opportunities to develop and modify preventive and intervention strategies, 
thereby minimizing adverse effects on fluid and solute removal as well as discomfort 
due to these strategies. In our study group, 70% of hypotension prone patients could be 
identified as having a reproducible hemodynamic response. In the remaining - combina-
tion -patients, alternating stroke volume and vascular resistance decrease caused the 
intradialytic hypotension. In this group there was a significant correlation between SVR 
and MAP, without a significant role for SV, resembling the pattern observed in the SVR-H 
group. It is hypothesized that paradoxical SVR decrease is the main cause of intradia-
lytic hypotension, except in a group of patients where vascular compliance is dimin-
ished to an extent that even slight changes in intravascular volume may lead to stroke  
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Table 2. Change in hemodynamic parameters during hemodialysis, from start of dialysis until 
moment of hypotension or equivalent. 
 
 
dMAP/SVR/SV/BV are changes in the different hemodynamic variables (%). IDH =  
type of intradialytic hypotension; stroke volume or systemic vascular resistance  
determined, or a combination of both. ‘–‘ = no hypotension occurred. 
Patient dMAP dSVR dSV DBV UF IDH 
A1 -29 -4 -35 -6 2,1 SV 
A2 -13 -17 -6 -7 1,5 - 
A3 0 38 -24 -3 2,8 - 
A4 -11 -17 0 -8 2,8 - 
A5 -15 -2 -12 -5 2,7 SV 
B1 -33 6 -52 -12 3,5 SV 
B2 -29 7 -52 -14 2,6 SV 
B3 -32 -19 -33 -13 2,9 SV 
B4 -28 10 -53 -11 2,8 SV 
B5 -7 -21 -8 -13 3,3 - 
C1 8 60 -40 -17 5,6 - 
C2 3 -2 -19 -13 4,8 - 
C3 -9 25 -28 -14 5,2 - 
C4 -19 13 -57 -6 3,9 SV 
C5 15 62 -36 -10 4,8 - 
D1 -24 28 -38 -6 1,9 SV 
D2 -16 54 -55 -6 2,0 SV 
D3 -48 -8 -43 -9 2,0 SV 
D4 -53 3 -60 -13 2,8 SV 
D5 -46 28 -56 -6 1,7 SV 
E1 -10 17 -36 -9 3,6 - 
E2 -24 17 -43 -13 3,5 SV 
E3 -16 -50 30 -5 2,8 SVR 
E4 -26 -26 -19 -7 2,6 Combi 
E5 -11 -5 -15 -11 3,6 - 
F1 -28 -13 -25 -18 4,3 Combi 
F2 -33 1 -44 -19 4,5 SV 
F3 -21 -11 -13 -17 4,2 Combi 
F4 4 33 -31 -15 4,4 - 
F5 5 -9 6 -6 3,3 - 
G1 -46 -42 -11 -13 3,1 SVR 
G2 -42 -49 3 -14 3,1 SVR 
G3 -29 -36 -3 -6 2,4 SVR 
G4 -7 -18 1 -12 3,2 - 
G5 -18 -41 2 -17 3,2 SVR 
H1 -18 8 -34 -2 3,5 SV 
H2 -33 -51 8 -7 2,9 SVR 
H3 -21 -40 13 -7 2,9 SVR 
H4 -18 -48 42 -3 1,8 SVR 
H5 -19 -15 -18 -6 2,9 - 
I1 -33 3 -42 -7 1,9 SV 
I2 -45 -23 -25 -7 1,9 Combi 
I3 -41 -26 -18 -4 2,8 Combi 
I4 -30 13 -45 -5 2,5 SV 
I5 -27 -11 -18 -4 2,7 Combi 
J1 -51 -36 -32 -15 4,7 Combi 
J2 -30 -11 -31 -13 4,1 Combi 
J3 -25 12 -38 -12 5,1 SV 
J4 -52 -57 11 -8 4,7 SVR 
J5 -34 -4 -38 -11 4,9 SV 
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volume decrease inducing hypotension. The group of patients with intradialytic hy-
potension without a recognisable pattern could be in a process where progressive vas-
cular dysfunction overrules primary vascular resistance decrease as the cause of hy-
potension.  
Our data show that there appear to be two types of categories of intradialytic hypoten-
sion. The first group consists of cardiac compromised patients, with narrow margins in 
cardiovascular reserve capacity. Prolonged or more frequent dialysis sessions can dimin-
ish the magnitude of variation in fluid state. The second group of patients experiences a 
decrease in systemic vascular resistance, which is inadequate during hypovolemia. In 
this (younger) group preventive strategies such as cool dialysate, sodium profiling or 
alpha-agonists might be of benefit.  
Non-invasive monitoring of hemodynamics during hemodialysis by means of electrical 
impedance cardiography provides an insight in intra-individual responses to hemodialy-
sis. Since decades it is known that without ultrafiltration, intradialytic hypotension does 
not occur (28). Furthermore, methods such as bioelectrical impedance analysis (BIA) 
provide a more accurate dry weight determination (29,30). However, prediction of oc-
currence of IDH based on changes in hydration state during hemodialysis remains diffi-
cult (31,32). Different pathophysiologic pathways leading to IDH have been identified, 
followed by as many strategies to prevent it, such as physiological (hypothermia, food 
avoidance) and pharmalogical (alpha-agonists) methods to improve SVR, as well as 
methods to improve SV by increasing venous return or myocardial contractility (33). All 
these interventions have their disadvantages in the sense of side effects or discomfort 
for the patient.  
We conclude that intradialytic hypotension has been thoroughly studied on a patho-
physiological basis, not on an individual basis. Non-invasive, bedside monitoring de-
vices provide the opportunity to classify the individual hypotension prone patient and to 
apply the most effective preventive strategy. Necessary is the intra-individual reproduci-
bility of the cause of IDH, appearing to be clear in 70% of hemodialysis patients.  
 
 
 
 
Figure 1. Characteristic hemodynamic response during hemodialysis in stroke volume  
dependent hypotension, which occurred at 3 hr.  
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Figure 2. Characteristic hemodynamic response during hemodialysis in vascular  
resistance dependent hypotension, which occurred at 3 hr.  
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ABSTRACT. 
 
After having monitored hemodynamics during hemodialysis, we examined autonomic 
nervous function in rest prior to a next dialysis session in 28 patients on chronic inter-
mittent hemodialysis. The aim was to compare intradialytically hypotensive with stable 
patients to assess whether blood pressure regulating mechanisms were related to basal 
autonomic function, assessed as heart rate variability (HRV) tested by means of the deep 
breathing test, the lying-to-standing test, and the Valsalva maneuver. Impedance cardio-
graphy was used to determine stroke volume and cardiac output during dialysis. In ad-
dition, blood pressure was registered automatically and systemic vascular resistance 
calculated. An on-line optical device monitored blood volume variation.  
Intradialytic hypotension was observed in 10 patients (36%). Systemic vascular resis-
tance in hypotensive patients decreased considerably (-14.0 ± 5.9%), while it increased 
in stable patients (+9.9 ± 4.6%, p = 0.004). Heart rate rose significantly in hypotensive 
patients (11.5 ± 3.8%) in comparison to stable patients (-0.2 ± 2.8%, p = 0.02). However, 
no significant differences in autonomic function were observed between hypotensive 
and stable patients. Although both groups showed impaired autonomic function, no sig-
nificant correlation between changes in hemodynamics during dialysis and autonomic 
function at rest could be ascertained.  
In conclusion, hypotension during hemodialysis is not related to a patient’s autonomic 
function at rest. This suggests that structural neuronal differences are not responsible 
for the severe decrease in systemic vascular resistance in intradialytic hypotension. 
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INTRODUCTION. 
 
Autonomic neuropathy is a well-known complication of uremia occurring in almost all 
uremic patients. It is probably caused by high levels of circulating uremic toxins (1), and 
results in a derangement of the para- and orthosympathetic nervous system, and a re-
duced end organ responsiveness to catecholamines (2). 
In the past, many authors have reported a dysfunction of the baroreflex arc to be one of 
the causes of hypotension during hemodialysis (HD) (3-5). In 1974, Kersh et al. first re-
lated intradialytic hypotension to autonomic neuropathy (6). In subsequent reports ef-
fort was made to locate the site of the dysfunction, which was concluded to be predomi-
nantly in the afferent limb of the baroreflex arc, and especially in the baroreceptors 
themselves (2,7). 
Several other investigators, however, reported contradictory results. Zoccali et al. for 
instance, showed no difference in autonomic function between hypotensive and non-
hypotensive patients during uremia, except for diabetic patients (8). Likewise, in other 
studies a causal relation between autonomic dysfunction and dialysis-induced hypoten-
sion could not be found (9-11). However, these studies did not provide further addi-
tional hemodynamic variables during HD. Recently, a diminished sympathetic response 
on blood volume decrease during HD was demonstrated in hypotension prone patients 
by means of spectral analysis of HRV (12-14). The sympatho-vagal balance, however, 
was significantly different between stable and unstable patients already at the begin-
ning of HD, when the process of HD itself had not had any influence on autonomic func-
tion yet. This suggests that the basal autonomic function in stable and unstable patients 
is different.  
Therefore, in the present study an attempt was made to clarify the role of the basal 
autonomic status in relation to changes in hemodynamics during HD. First, 28 patients 
were monitored hemodynamically during a standard HD and subsequently divided into a 
hypotensive and a stable group. In this dialysis session blood pressure (MAP), stroke 
volume (SV), heart rate (HR), cardiac output (CO), systemic vascular resistance (SVR), and 
blood volume (BV) were monitored. Second, we tested the cardiovascular reflex arc in 
the intradialytically hypotensive and the stable dialysis patients at rest prior to a next 
dialysis session with a standard battery of three autonomic function tests.  
 
PATIENTS AND METHODS. 
 
Patients. 
Based on cardiovascular stability during a previously monitored dialysis session, 28 pa-
tients on chronic intermittent hemodialysis were divided into a hypotensive group (H; n 
= 10) and a stable group (non-H; n = 18). A hypotensive episode was defined as a sud-
den decrease of systolic blood pressure of more than 30 mmHg or an absolute systolic 
blood pressure below 90 mmHg. Based on past dialysis performance all hypotensive pa-
tients appeared to have hypotensive episodes in more than 30% of the dialysis sessions, 
whereas stable patients experienced symptomatic hypotension in less than 5% of the 
sessions.  
Patient characteristics of the two groups are provided in Table 1. No significant differ-
ences in age, HD history and dry weight were present. Patients were dialyzed 9 to 15 
hours per week divided over 2-3 sessions with biocompatible polysulphone membranes. 
Bicarbonate was used as buffer and heparin as anticoagulant. Blood flow varied from 
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200 to 350 ml/min, whereas the dialysate flow was 500 ml/min and the dialysate so-
dium concentration 141 mmol/L. Dry body weight was determined individually by the 
attending physician on clinical grounds such as blood pressure, central venous pres-
sure, and the presence of peripheral and/or pulmonary edema. Ultrafiltration (UF) vol-
ume was calculated as the difference of the pre-dialysis weight and dry weight. Cardio-
vascular medication was withheld on dialysis days to minimize interference with intra-
dialytic blood pressure regulation. To minimize interference of antihypertensive medica-
tion on autonomic function, the autonomic function tests were performed on a dialysis 
day, prior to dialysis. Complete withdrawal of antihypertensive medication for the dura-
tion of the experiments was not performed, because of the risks for the clinical status 
of the patients. Infusion of saline or gelatin (Gelofusin®) was used to treat hypotensive 
episodes. All patients gave their informed consent for participating in the studies. 
Hemodynamic variables during dialysis. 
In a dialysis session prior to the autonomic function tests every patient was monitored 
regarding his cardiovascular stability. Electrical impedance cardiography was performed 
to monitor SV at the start of dialysis and every hour thereafter using the IPG-104 imped-
ance Mini-Lab (RJL Systems, Detroit, USA, and Equip Medikey, Gouda, The Netherlands) 
(15). CO was calculated from the HR obtained from an ECG and the SV. SVR was calcu-
lated according to Ohm’s law, as (MAP/CO) * 80, where MAP is mean arterial pressure. 
The constant value 80 in the expression above makes it possible to express SVR in 
units: dynes/s/cm-5. Variation in BV was monitored continuously by means of an optical 
device detecting an increase in hematocrit by the reflection of infrared light by erythro-
cytes (Critline®, In-Line Diagnostics, Riverdale (Utah), USA). BV was expressed in total 
percentage change compared to the pre-dialysis value as well as percentage change per 
liter of UF. Blood pressure was recorded every 30 minutes in stable condition or every 
10 minutes when any symptom of a decrease in blood pressure arose, such as dizzi-
ness, muscle cramps, perspiration, or frequent yawning. The same investigator using a 
sphygmomanometer always performed the blood pressure measurements. Finally, total 
body water (TBW) was assessed by means of whole body impedance measurements at 
the start and at the end of the dialysis session (16). 
Table 1. Characteristics of the hypotension-prone (H) and the stable (non-H) patients. 
 
* Expressed as mean ± SEM. No significant differences between the two groups. 
 H non-H 
Number 10 18 
Sex (f:m) 5:5 5:13 
Diabetes Mellitus 1/10 2/18 
Antihypertensive Drugs 8/10 6/18 
Age (yrs)* 45 ± 5.0 51 ± 4.2 
Dry weight (kg)* 62.8 ± 2.9 67.9 ± 4.1 
Body surface area (m2) 1.70 ± 0.04 1.78 ± 0.06 
History of HD (months)* 53 ± 13 83 ± 17 
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Autonomic function tests. 
A battery of three autonomic function tests based on cardiovascular reflexes was per-
formed to gain insight in the patient’s autonomic activity. These tests were 1) a deep 
breathing test to assess parasympathetic heart rate control, 2) a lying-to-standing test 
to assess both the cardiac reflex arc (sympathetic as well as parasympathetic) and pe-
ripheral vasomotor function, and 3) a Valsalva maneuver to determine both sympathetic 
and parasympathetic function. During these tests the variability in the length of the R-R 
intervals on the ECG was measured. R-R intervals were automatically obtained by a PC-
based data acquisition system from a hardware QRS-detector (band-pass filtered adap-
tive R-wave level detection), using a bipolar chest lead. The data acquisition program 
precisely guided the test performance and computed the test variables as well. All tests 
were performed at rest just before a dialysis session. As autonomic function declines 
with increasing age, age-dependent reference values were applied according to Piha 
(17). In the latter study the expected values corrected for age were provided per test, 
with the lower 10 percentile as lowest normal value and the lower 2.5 percentile as the 
lowest borderline value. Values under the 2.5 percentile were considered abnormal. To 
obtain a simple measure for autonomic function, every patient was given a normal (1) or 
abnormal (0) qualification, according to the age-related reference values, for each of the 
four autonomic variables (IE-difference (bpm); Max/min ratio; HRmax (bpm); Valsalva Ra-
tio) computed from the three tests (see below). The sum of the four test qualifications 
was defined as the Total Autonomic Index and considered as an overall index of auto-
nomic function, ranging from 0 (severe dysfunction) to 4 (normal). 
 
1) Deep breathing test. 
After a period of supine rest for five minutes the patient was asked to breath deeply for 
one minute in a fixed rhythm of six breaths per minute. The inspiration-expiration dif-
ference (IE-value) was defined as the mean of the differences between maximum and 
minimum heart rate (in bpm) over the consecutive deep breaths. This test was per-
formed twice and the average was calculated. The IE-value is almost exclusively a meas-
ure for (cardiac) parasympathetic function since rapid beat-to-beat variation of heart 
rate can only be mediated by the vagal nerve (18). 
 
2) Lying-to-standing test. 
Standing up from supine position produces a characteristic cardiovascular response, 
with significant changes in heart rate and peripheral vasoconstriction. Blood pooling in 
the lower part of the body provokes a decrease in blood pressure, which is counteracted 
instantly by a vagally mediated initial tachycardia followed by a sympathetically induced 
prolonged tachycardia. The maximum increase in heart rate (HRmax, in bpm) is, there-
fore, informative about the cardiac reflex arc, sympathetic as well as parasympathetic. 
Subsequently, a sympathetic vasomotor reflex induces peripheral vasoconstriction. The 
hereby increasing peripheral resistance and partly normalizing venous return result in 
almost complete recovery of blood pressure, and consequently in a relative bradycardia. 
The ratio between the maximum HR around the 15th beat after standing up and the 
minimum HR around the 30th beat after standing up (Max/min ratio) thus indirectly 
provides information about the peripheral sympathetic function (19). 
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3) Valsalva maneuver. 
The patient in a relaxed sitting position was asked to take a full deep breath and blow 
into a mouthpiece connected to a manometer and to maintain an expiratory pressure of 
30 mmHg for 15 seconds, and to finally expire and relax for another 45 seconds. After 
practicing, the maneuver was repeated twice and the obtained average variable was 
used. The reflex response to this maneuver consists of two phases: 1) an immediate 
(vagal) and sustained (sympathetic) tachycardia and peripheral vasoconstriction during 
strain evoked by the drop in blood pressure due to obstruction of venous return, 2) an 
overshoot in blood pressure after pressure release due to normalizing stroke volume 
ejected in a still constricted arterial system resulting in a strong immediate reflex brady-
cardia (vagally mediated). The ratio between the longest R-R interval within 15 seconds 
after release and the shortest interval during strain is defined as the Valsalva Ratio (VR) 
(18). 
 
Statistical analysis. 
Differences between the two groups were analyzed by means of the unpaired Student’s 
t test, and between different time intervals during dialysis within one group by means of 
the paired Student’s t test and the repeated measures analysis of variance, when appro-
priate. The relationship between different variables was evaluated using Pearson’s corre-
lation coefficient. Interdependency between variables was tested by multiple linear re-
gression analysis. Chi square tests were performed to assess significant differences be-
tween H and non-H groups in distributions of antihypertensive medication and auto-
nomic function scores. P values < 0.05 were considered significant. 
 
RESULTS. 
 
Hemodynamic variables during dialysis. 
Intradialytic hypotension was observed in 10 patients (36%). The hypotensive episodes 
occurred on average after three hours of dialysis. At the moment of hypotension, abso-
lute values only differed significantly in MAP (H 71 ± 5 vs. non-H 88 ± 3 mmHg, p < 
0.001). SV and TBW tended to be higher in the stable patients, but equalized in both 
groups when expressed per square meter body surface area (BSA) or kilogram of body 
weight, respectively (see Table 2).  
Multiple linear regression with relative values, i.e. the change of a variable from the 
start of dialysis until the moment of hypotension or the corresponding moment in time 
in the non-H group, revealed a predominant role for the change in SVR (dSVR) in the de-
cline of MAP (dMAP) in both groups (see Table 3). Indeed, the SVR increased adequately 
in the stable patients (+9.9 ± 4.6%), whereas the hypotensive patients showed a marked 
decrease (-14.0 ± 5.9%, p = 0.004) (see Table 4).  
No significant correlation was found between dMAP and dSV in either of the groups with 
simple regression analysis. However, the SV showed an almost equally important role in 
the decrease of MAP according to the multiple regression analysis. 
There were significant differences in decrease in BV between stable and unstable pa-
tients, due to a greater UF volume in hypotensive patients (see Table 4). However, ac-
cording to the multiple as well as the simple regression analysis, there was no signifi-
cant influence of the dBV on blood pressure variation (see Table 3). 
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Table 2. Mean hemodynamic variables (SEM) at the start and end of dialysis, and at the moment 
of hypotension (tH) in group H or the corresponding moment (t3h) in group non-H. 
 
* P < 0.001 within group; # P < 0.05 within group; 1 P < 0.001 H compared to H;  2 P < 0.05 H 
compared to H. § = dynes/s/cm-5 
 
 
Table 3. Multiple regression coefficients (ß) and Pearson’s correlations (r) for the relation be-
tween trends in hemodynamic variables and decrease in blood pressure (dMAP). 
 
 
  H   non-H  
 start tH end start t3h end 
MAP (mmHg) 95 (3.7) 71 (4.6) 76 (4.5)* 93 (2.3) 88 (2.6)1 88 (9.4)2,# 
SV (ml) 56.4 (9.1) 46.0 (7.7) 43.2 (7.1)# 72.6 (6.6) 65.2 (6.4) 62.0 (6.4)* 
SVI (ml/m2) 33.7 (5.7) 27.3 (4.6) 25.6 (4.2) 40.8 (3.4) 36.5 (3.4) 34.7 (3.4) 
HR (bpm) 73 (3.7) 81 (3.7) 81 (3.7)* 73 (2.7) 72 (2.6) 74 (2.6) 
CO (l/min) 4.0 (0.6) 3.5 (0.5) 3.3 (0.5)# 5.2 (0.5) 4.6 (0.4) 4.5 (0.5)* 
SVR (§) 2294 (321) 2032 (381) 2324 (475) 1732 (244) 1823 (217) 1914 (236) 
TBW (l) 36.0 (2.3)  30.9 (2.1)* 41.0 (2.8)  34.6 (2.0)* 
TBW/kg (l/kg) 0.56 (0.03)  0.50 (0.03) 0.59 (0.02)  0.52 (0.02) 
UF (l) 0 2.6 (0.2) 2.9 (0.2)# 0 1.8 (0.1)1 2.4 (0.2)* 
 non-H (n = 18)  H (n=10)   
 mult. regression  correlation dMAP mult. regression  
 ß p r p ß p r p 
dSVR 1.73 < 0.001 0.66 0.003 1.30 < 0.001 0.72 0.02 
dSV 1.43 < 0.001 -0.15 0.56 0.97 0.001 -0.20 0.58 
dHR 0.47 0.02 -0.03 0.91 0.49 0.01 0.44 0.20 
dBV -0.02 0.90 -0.19 0.46 -0.06 0.56 -0.12 0.75 
correlation dMAP 
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Table 4. Percentage change in hemodynamic variables (SEM) from the start of dialysis until the 
moment of hypotension (H) or the corresponding moment (non-H). 
 
BV/UF = blood volume per liter ultrafiltration. 
 
 
Table 5. Results of autonomic function tests (SEM) of hypotensive (H) and stable (non-H) pa-
tients. Normal (N), borderline (B) or abnormal (A) qualification is provided in number of pa-
tients. 
 
IE = inspiration - expiration difference; HRmax = maximum increase in heart rate after standing 
up; Max/min = ratio between maximum and minimum heart rate after standing up; VR = Val-
salva ratio; NS = not significant. 
 H non-H P  value 
MAP (%) -25.4 (3.9) -5.1 (2.3) <0.001 
SV (%) -19.5 (5.5) -10.9 (3.2) 0.16 
HR (%) 11.5 (3.8) -0.2 (2.8) 0.02 
CO (%) -11.1 (5.3) -11.9 (2.9) 0.89 
SVR (%) -14.0 (5.9) 9.9 (4.6) 0.004 
BV (%) -10.6 (1.7) -5.8 (0.9) 0.01 
BV/UF (%/l) -4.2 (0.6) -3.2 (0.5) 0.22 
 H   
 mean N    B   A mean N    B   A P  value 
Deep Breathing IE (bpm) 10 (2) 5    4    1 11 (2) 11   4    3 NS 
Lying-to-standing HRmax (bpm) 15.0 (2.0) 2    2    6 14.5 (1.6)  5    6    7 NS 
Max/min 1.16 (0.04) 2    7    1 1.15 (0.03)  9    5    4 NS 
Valsalva Maneuver VR 1.27 (0.05) 6    3    1 1.40 (0.08) 14   1    3 NS 
Total Autonomic Index 2.30 (0.34)  2.58 (0.30)  NS 
non-H 
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Autonomic function tests. 
No differences in responses on the autonomic tests could be demonstrated between the 
hypotensive and the non-hypotensive group (Table 5). When the three diabetics were 
excluded, the results did not change statistically, although the diabetics did have the 
lowest scores on all tests (data not shown). The identical basal autonomic status, ex-
pressed as HRV variables, did not show any significant correlation with variations in 
MAP and SVR during HD (p > 0.1 for all correlations, data not shown). More specifically, 
no correlation was found between the Max/min, a variable reflecting mainly sympathetic 
function, and the dSVR, principally regulated by sympathetic tonus, in group H (r = 
0.31, p = 0.39), nor in group non-H (r = -0.17, p = 0.51). 
The Total Autonomic Index averaged 2.30 ± 0.34 in the hypotensive patients, whereas 
the stable patients reached 2.58 ± 0.30 (p > 0.5). A chi square test performed on the 
distribution into normal and not-normal (i.e. borderline + abnormal) autonomic function 
showed no significant differences for the four autonomic function variables (p > 0.2 for 
all variables). All four autonomic function variables were negatively correlated with age 
(p < 0.02 for all correlations), justifying the use of age-dependent reference values. 
 
DISCUSSION. 
 
In our study we examined if a direct relation between intradialytic hemodynamic vari-
ables and autonomic function variables at rest could be established. The observed se-
vere decrease in SVR in hypotensive patients, compared to the rise in SVR in stable pa-
tients required a re-evaluation of the involvement of the autonomic function in intradia-
lytic hypotension. However, measured at rest, no difference in autonomic function was 
observed between stable and hypotensive patients, and no correlation with change in 
MAP or SVR was present. Combining direct measurements of autonomic function and 
intradialytic hemodynamics, this clearly demonstrates the irrelevance of the pre-existent 
autonomic function at rest.   
Remarkably, BV appeared to have no significant influence on blood pressure, indicating 
that hypovolemia was not the single cause of intradialytic hypotension. Perhaps increas-
ing age and comorbidity in the dialysis population are reasons for a more complex and 
multifactorial origin of the intradialytic hypotensions today. Although a decrease in SVR 
becomes currently more accepted as an important inductor of intradialytic hypotension, 
the cause for this SVR decrease remains to be clarified. Our study did not include intra-
dialytic measurements of vasoactive substances as catecholamines and nitric oxide, 
which are powerful determinants of SVR. Results so far in this area are still controver-
sial.  
In an attempt to elucidate the fall in SVR during HD, some authors have claimed a role 
for the Bezold-Jarisch reflex (20), a mechanically induced sympatho-inhibitory reflex 
originating from the ventricles to protect the heart against structural damage under 
conditions of extremely low CO (21). Ligtenberg and colleagues even suggested that a 
sympathetic impulse, eliciting an adequate reaction at rest, provoked this sympatho-
inhibitory reflex under conditions of low CO, as can also be seen in normals undergoing 
lower body negative pressure (22). However, to conclude the activity of such a reflex 
causing sympatho-inhibition, a relative bradycardia must be present. Therefore, Santoro 
et al. made a distinction between tachycardiac and bradycardiac hypotensions (23). Very 
recently, Zoccali et al. demonstrated that this bradycardia occurred only in up to 20% of 
all intradialytic hypotensive episodes and was indicative for underhydration, requiring 
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adjustment of the patient’s dry weight (24). In our population no bradycardia occurred 
during hypotensive episodes, suggesting a different process being involved in the unfa-
vorable decrease in SVR during hypovolemia. 
Recently, it was suggested that autonomic function deteriorates during HD (12, 13, 14). 
Analysis of HRV with spectral analysis showed no increase in sympathetic tonus during 
HD in hypotensive patients. However, no age-matched groups were studied and, there-
fore, it cannot be excluded that the differences between the groups were due to an age-
dependent decline in autonomic function. Furthermore, differences in sympatho-vagal 
balance were present at the start of HD, suggesting differences in basal autonomic 
status. In contrast, Ligtenberg and coworkers reported no change in autonomic function 
during HD, neither in stable nor in hypotensive patients (25). Thus, additional research 
with spectral analysis of HRV during HD is required to elucidate the role of autonomic 
dysfunction as a cause of intradialytic hypotension, with age-matched patient groups 
and simultaneous monitoring of intradialytic hemodynamics. Although age-dependency 
in autonomic function has often been observed, age-corrected reference values still are 
scarcely described and consensus about standard reference values has not been 
reached so far. Our data confirm the age-dependency of autonomic function by strongly 
significant negative correlations between the four autonomic variables and age. 
Finally, it was remarkable in our study that the change in measured TBW between the 
start and the end of HD considerably overestimated the total UF volume (see Table 2). 
This might be due to excretion of electrolytes during HD, reducing total ionic mass. Im-
pedance measurements depend upon the conductance of an electrical current by elec-
trolytes in TBW. Loss of electrolytes results in a higher electrical resistance. Since electri-
cal resistance and TBW are inversely correlated, calculated TBW at the end of HD will be 
underestimated. 
To conclude, age-matched hypotensive and stable hemodialysis patients are identical in 
basal autonomic function at rest. Nevertheless, hypotensive patients decrease signifi-
cantly more in SVR during HD. There was a highly significant relation between blood 
pressure and SVR variation, but no causal relationship could be established between 
basal autonomic function tests and blood pressure or SVR variation during HD. This 
suggests a different underlying cause for the fall in SVR than autonomic dysfunction at 
rest. Furthermore, with a combination of electrical impedance cardiography and on-line 
blood volume monitoring it is possible to guard dialysis patients non-invasively during 
hemodialysis with respect to intradialytic hemodynamics, possibly combined with auto-
nomic function testing. 
 
REFERENCES 
 
 1.  Fraser CL, Arieff AI: Nervous system complications in uremia. Ann Intern Med 109:143-
153, 1988 
 2.  Campese VM, Romoff MS, Levitan D, Lane K, Massry SG: Mechanisms of autonomic nerv-
ous system dysfunction in uremia. Kidney Int 20:246-253, 1981 
 3.  Lilley JJ, Golden J, Stone RA: Adrenergic regulation of blood pressure in chronic renal fail-
ure. J Clin Invest 57:1190-1200, 1976 
 4.  Takahashi H, Matsuo S, Toriyama T, Kawahara H, Hayano J: Autonomic dysfunction in 
hemodialysis patients with persistent hypotension. Nephron 72:418-423, 1996 
Autonomic dysfunction 
 
61 
 5.  Travis M, Henrich WL: Autonomic nervous system and hemodialysis hypotension. Semin 
Dial 2:158-162, 1989 
 6.  Kersh ES, Kronfield SJ, Unger A, Popper RW, Cantor S, Cohn K: Autonomic insufficiency in 
uremia as a cause of hemodialysis-induced hypotension. N Engl J Med 290:650-653, 
1974 
 7.  Heber ME, Lahiri A, Thompson D, Raftery EB: Baroreceptor, not left ventricular, dysfunc-
tion is the cause of hemodialysis hypotension. Clin Nephrol 32:79-86, 1989 
 8.  Zoccali C, Ciccarelli M, Maggiore Q: Defective reflex control of heart rate in dialysis pa-
tients: evidence for an afferent autonomic lesion. Clin Sci (Lond) 63:285-292, 1982 
 9.  Bondia A, Tabernero JM, Macias JF, Martin-Luengo C: Autonomic nervous system in 
haemodialysis. Nephrol Dial Transplant 3:174-180, 1988 
 10.  Naik RB, Mathias CJ, Wilson CA, Reid JL, Warren DJ: Cardiovascular and autonomic re-
flexes in haemodialysis patients. Clin Sci (Lond) 60:165-170, 1981 
 11.  Nies AS, Robertson D, Stone WJ: Hemodialysis hypotension is not the result of uremic 
peripheral autonomic neuropathy. J Lab Clin Med 94:395-402, 1979 
 12.  Cavalcanti S, Chiari L, Severi S, Avanzolini G, Enzmann G, Lamberti C: Parametric analysis 
of heart rate variability during hemodialysis. Int J Biomed Comput 42:215-224, 1996 
 13.  Cavalcanti S, Severi S, Chiari L, Avanzolini G, Enzmann G, Bianco G, Panzetta G: Auto-
nomic nervous function during haemodialysis assessed by spectral analysis of heart-rate 
variability. Clin Sci (Lond) 92:351-359, 1997 
 14.  Enzmann G, Bianco F, Paolini F, Panzetta G: Autonomic nervous function and blood vol-
ume monitoring during hemodialysis. Int J Artif Organs 18:504-508, 1995 
 15.  Handt A, Farber MO, Szwed JJ: Intradialytic measurement of cardiac output by thermodi-
lution and impedance cardiography. Clin Nephrol 7:61-64, 1977 
 16.  Lukaski HC, Johnson PE, Bolonchuk WW, Lykken GI: Assessment of fat-free mass using 
bioelectrical impedance measurements of the human body. Am J Clin Nutr 41:810-817, 
1985 
 17.  Piha SJ: Cardiovascular autonomic reflex tests: normal responses and age-related refer-
ence values. Clin Physiol 11:277-290, 1991 
 18.  Ewing DJ: Recent advances in the non-invasive investigation of diabetic autonomic neu-
ropathy. In: Autonomic Failure edited by Bannister R, New York, Oxford University Press, 
1990, pp 667-689 
 19.  Wieling W: Standing, orthostatic stress, and autonomic function. In: Autonomic Failure 
edited by Bannister R, New York, Oxford University Press, 1990, pp 309-320 
 20.  Converse RL, Jr., Jacobsen TN, Jost CM, Toto RD, Grayburn PA, Obregon TM, Fouad-
Tarazi F, Victor RG: Paradoxical withdrawal of reflex vasoconstriction as a cause of 
hemodialysis-induced hypotension. J Clin Invest 90:1657-1665, 1992 
 
Chapter 5 
 
62 
 21.  Schadt JC, Ludbrook J: Hemodynamic and neurohumoral responses to acute hypovolemia 
in conscious mammals. Am J Physiol 260:H305-H318, 1991 
 22.  Ligtenberg G, Blankestijn PJ, Oey PL, Wieneke GH, van Huffelen AC, Koomans HA: Cold 
stress provokes sympathoinhibitory presyncope in healthy subjects and hemodialysis 
patients with low cardiac output. Circulation 95:2271-2276, 1997 
 23.  Santoro A, Mancini E, Spongano M, Rossi M, Paolini F, Zucchelli P: A haemodynamic 
study of hypotension during haemodialysis using electrical bioimpedance cardiography. 
Nephrol Dial Transplant 5 Suppl 1:147-153, 1990 
 24.  Zoccali C, Tripepi G, Mallamaci F, Panuccio V: The heart rate response pattern to dialysis 
hypotension in haemodialysis patients. Nephrol Dial Transplant 12:519-523, 1997 
 25.  Ligtenberg G, Blankestijn PJ, Boomsma F, Koomans HA: No change in automatic function 
tests during uncomplicated haemodialysis. Nephrol Dial Transplant 11:651-656, 1996 
 
 
 
 
 
 
 
6 
 
 
 
The effect of profiled hemodialysis on 
intradialytic hemodynamics when a 
proper sodium balance is applied 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
B Straver, PMJM de Vries, AJM Donker, PM ter Wee 
 
Blood Purif 2002;20:364-369 
Chapter 6 
 
64 
ABSTRACT 
 
Background. Profiled hemodialysis has been claimed to ameliorate intradialytic compli-
cations such as hypotension. Frequently, these profiles are based on providing the pa-
tient with an accumulating sodium load. This increases the risk on interdialytic compli-
cations, such as hypertension and increased weight gain. The present study investigated 
the effect of profiled hemodialysis, without an accompanying sodium loading, on intra-
dialytic hemodynamics in stable hemodialysis patients. 
Methods. In eight stable hemodialysis patients a standard dialysis (S-HD) was compared 
to a decreasing Na+-profiled dialysis (Na-HD), and an ultrafiltration profiled dialysis (UF-
HD). Care was taken to have the sodium balances similar during these sessions. The pa-
tients were monitored non-invasively during dialysis with respect to their cardiac per-
formance by means of electrical impedance cardiography, their variation in blood vol-
ume by means of an on-line optical measurement, and their hydration state by means of 
body impedance analysis. 
Results. The sodium balance and the mean arterial sodium concentrations were similar 
in the three treatments. Intradialytic hemodynamics during UF-HD were similar to those 
of S-HD. However, Na-HD improved blood pressure preservation, remarkably without 
significant blood volume preservation, due to a better stroke volume preservation in the 
first hour of dialysis. 
Conclusion. Sodium-balanced, Na-profiled hemodialysis improves blood pressure pres-
ervation in stable hemodialysis patients without providing the patients with a sodium 
load. This effect is due to a better stroke volume preservation early in dialysis, without a 
significant reduction in blood volume decrease. UF-HD, as mono-therapy, has no benefi-
cial effect on intradialytic hemodynamics in stable patients. 
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INTRODUCTION 
 
Intradialytic hypotension remains one of the main problems during hemodialysis (HD), 
resulting in discomfort for the patient as well as reduced dialysis efficacy. Although its 
causes are still debated, various efforts have been made to prevent or predict hypoten-
sive episodes in the individual patient. In recent years, profiled hemodialysis has gained 
increasing interest as a simple method to reduce hypotensive episodes. Decreasing ul-
trafiltration (UF) profiles aim at a better blood volume (BV) preservation by extracting 
the major part of the total UF volume in the first part of HD, when the patient is the 
most overhydrated. Profiles with a decreasing sodium concentration in the dialysate are 
thought to linearise the inevitable osmotic differences between the intra- and extracellu-
lar compartments by exchanging removed urea for sodium. Water inflow into the intra-
cellular compartment is hereby avoided or diminished, and capillary refill will thus be 
optimised. However, most applied sodium profiles are based on providing the patient 
with a sodium overload, starting with a high dialysate sodium which decreases during 
dialysis until the normal sodium concentration used in standard HD. It is well known 
that most HD patients require antihypertensive medication, that more than 60% have 
left ventricular hypertrophy, and that the main cause of death is of cardiovascular origin 
(1). Notwithstanding these facts, in many studies an adequate sodium balance through-
out the dialysis session was not calculated. It was assumed that sodium balance did not 
change, generally based on the findings that interdialytic complications hadn’t in-
creased significantly. In these studies, relevant parameters were frequently not pro-
vided, such as intradialytic hemodynamics, pre- and postdialytic sodium concentration, 
sodium balance, and blood volume variation (2-9).  
The present study was designed to evaluate the value of profiling while maintaining a 
similar sodium balance in all applied dialysis modalities. A decreasing UF-profile, a de-
creasing Na-profile, and a standard hemodialysis were compared in eight stable patients 
on chronic intermittent hemodialysis. Hemodynamically stable patients were studied to 
investigate physiological effects of profiled HD on intradialytic hemodynamics. Varia-
tions in BV, mean arterial pressure (MAP), stroke volume (SV), heart rate (HR), cardiac 
output (CO), and systemic vascular resistance (SVR) were assessed. In addition, pre- and 
postdialysis sodium concentration were recorded as well as afferent and efferent so-
dium flux, in order to monitor the sodium balance. 
 
SUBJECTS AND METHODS 
 
Subjects 
Eight stable patients (2F/6M; mean age ± SEM: 63 ± 6 years) on chronic intermittent 
hemodialysis for on average 30 months (range: 2 - 68) were enrolled in this study. Dry 
body weight was determined individually by the attending physician on clinical grounds 
such as blood pressure, absence of peripheral and/or pulmonary oedema, and central 
venous pressure. Ultrafiltration volume was based on the difference between pre-
dialysis and dry weight. Patients experiencing a symptomatic decrease in supine systolic 
blood pressure of >30 mmHg or an absolute systolic blood pressure of < 90 mmHg dur-
ing dialysis, accompanied by hypotensive symptoms such as dizziness, frequent yawn-
ing or perspiration, were defined as hypotensive. Patients enrolled in this study were 
considered to be hemodynamically stable, i.e. no occurence of symptomatic hypoten-
sion in the prior 10 dialysis sessions. All but two patients used antihypertensive drugs, 
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such as a-blockers, Ca-antagonists and ACE-inhibitors. No nitrates were used, and 3 pa-
tients used ß-blockers. To minimize confounding, antihypertensive medication was with-
held on the day of dialysis. Withdrawal of this medication during a  larger  period was 
clinically not acceptable. None of the patients suffered from clinically manifest cardio-
vascular disease during the course of the study.  Informed consent was obtained from 
all patients. 
 
Dialysis modalities 
All patients were dialysed three times 4 hours per week with biocompatible polysulfone 
membranes of 1.8 m2 (Fresenius AG, Bad Homburg, Germany) on the Integra dialyzer 
(Hospal International, Lyon, France), using bicarbonate as buffer and heparin as antico-
agulant. Blood flow was set at 250 ml/min, whereas the dialysate flow was 500 ml/min, 
with a constant dialysate temperature of 37.0° C. Blood samples were drawn from the 
arterial as well as the venous bloodline. Na+ was determined at the beginning of the ses-
sion and hourly thereafter, whereas urea and creatinine were assessed at the start and 
at the end of each session. All efferent dialysate was collected hourly, in which Na+ and 
urea were measured. The collection of the efferent dialysate was performed by leading 
the waste-tubes to a water container, which was weighed hourly and emptied after tak-
ing a stirred sample for sodium determination. Afferent dialysate was sampled from a 
machine-integrated port for Na+. Sodium determination was performed by the hospital 
laboratory using ion sensitive electrodes. Kt/V was calculated according to Daugirdas 
(10):  
Kt/V = -ln (R - 0.03 - 0.75 * UF volume (l) / post HD weight (kg)) 
The afferent Na+ load was calculated as [Na+]D * QD, where [Na
+]D is the sodium concen-
tration in the dialysate (in mmol/L) and QD the dialysate flow (in ml/min), defined as the 
collected dialysate volume minus the UF volume to correct dialysate pump deviances. 
The efferent Na+ load was calculated as [Na+]c * volumec , where c stands for the col-
lected dialysate. Finally, the Na+ balance was the difference between the afferent and 
efferent Na+ load. 
Three different types of HD were applied to the patients, in random order but on the 
same day of the week for each patient to prevent differences by alternating interdialytic 
intervals:  
 1) One standard HD (S-HD), with a standard dialysate conductivity of 14.1 mS/cm 
similar to a sodium concentration of 141 mmol/L;  
 2) One HD with a decreasing UF-profile (UF-HD), whereby 40% of the total UF vol-
ume was removed in the first hour, and 20%, 30%, and 10% respectively in the second, 
third and fourth hour. The conductivity was kept constant at 14.1 mS/cm;  
 3) One HD with a decreasing Na+-profile (Na-HD), containing a dialysate conductiv-
ity of 15.2 mS/cm (= 152 mmol/L) in the first hour, followed by 13.7 (= 137 mmol/L), 
14.5 (= 145 mmol/L), and 13.0 mS/cm (130 mmol/L) in the remaining three hours, re-
spectively. Averaged over the entire HD session, the mean dialysate conductivity of the 
Na-profile was 140.7 mmol/L and therefore equalled the dialysate conductivity of the 
standard HD session.  
Both the decreasing UF- and Na-profiles were not established according to a linear 
model, but to an alternating model. This was done in order to facilitate differentiation in 
induced changes in hemodynamic variables as a result of the profiles, due to the 
hereby-increased differences between the hourly steps. 
 
Profiled hemodialysis 
 
67 
 
Hemodynamic variables 
Blood pressure was recorded using an automatic cuff sphygmomanometer every 30 
minutes and on occurrence of symptoms of hypotension, such as dizziness, muscle 
cramps, perspiration, or frequent yawning. Blood volume variation was monitored by 
means of an on-line optical device (Critline®, In-Line Diagnostics, Riverdale (Utah), USA), 
based on the non-invasive and continuous measurement of changes in hematocrit, 
which is inversely correlated to BV variation (11). Erythrocyte counts, hematocrit, hemo-
globin concentration and red cell indices were performed on hourly drawn arterial blood 
samples as control determinations of the BV monitoring. SV recordings were performed 
hourly utilising electrical impedance cardiography (IPG-104 impedance Mini-Lab by RJL 
Systems, Detroit, USA, and Equip Medikey, Gouda, The Netherlands), a valid, non-
invasive, bedside method to determine SV based on intrathoracic changes in electrical 
resistance due to heart pumping (12-15). Simultaneous ECG recordings provided HR, 
and CO was calculated as SV * HR. In addition, SVR was obtained using the formula SVR 
= (MAP / CO) * 80, expressed as dynes/s/cm-5.  
 
Total body water 
Total  body water (TBW) and extracellular water (ECW) were assessed at the start and the 
end of treatment by means of the whole body impedance method according to Lukaski 
(16). TBW was expressed as percentage of the body weight. ECW was expressed as per-
centage of TBW. Intracellular water (ICW) was then calculated as the difference between 
TBW and ECW, again expressed as percentage of TBW. For all three compartments rela-
tive changes from the start until the end of the treatment were calculated, expressed 
respectively as dTBW, dECW, and dICW (all in %). 
 
Statistical analysis 
Paired Student’s t-test was used to test for differences in the two profiled dialyses com-
pared to the standard HD, provided a normal distribution. The time effect of dialysis on 
hemodynamics per dialysis mode and changes in time between different dialysis mo-
dalities were analysed by means of repeated measures analysis of variance, again pro-
vided a normal distribution. P values < 0.05 were considered significant. When perform-
ing nonparametric tests, no differences in results were found. 
 
Table 1. Sodium dynamics in the three hemodialysis modalities. 
 
Values are expressed as their mean ± SEM. No significant differences compared to standard HD. 
[Na+]art = mean arterial sodium concentration; [Na
+]D = mean dialysate sodium concentration. 
 Standard HD UF-profile Na-profile 
[Na+]art (mmol/L) 140.1 ± 0.7 140.0 ± 0.7 140.8 ± 0.6 
[Na+]D  (mmol/L) 140.0 ± 0.8 140.2 ± 0.9 140.7 ± 0.8 
Na+ load aff. (mmol) 16736 ± 91 16655 ± 81 16692 ± 190 
Na+ load eff. (mmol) 17098 ± 126 17094 ± 100 17051 ± 186 
Na+ balance (mmol) -362 ± 66 -440 ± 68 -359 ± 0.38 
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RESULTS 
 
Intradialytic complications requiring interventions occurred in three of the 24 treat-
ments. One patient experienced a sudden hypotension at three hours of the S-HD. An-
other patient, in 10 previous HD sessions without complications, faced a hypotension 
necessitating saline infusions in the last 15 minutes of the S-HD, while in the Na-HD se-
vere cramps occurred requiring cessation of dialysis. The Kt/V (mean 1.07 ± 0.02 SEM, 
range 0.80-1.32) did not differ between the three sessions and neither did the total UF 
volume (mean 2.8 ± 0.1 SEM, range 1.0-4.2). Concerning the sodium dynamics, the pa-
tients did not differ significantly between the three dialysis modalities in arterial Na+ 
concentration and Na+ balance (see Table 1). Concerning the intradialytic hemodynamic 
variables, Table 2 shows the absolute values at the start and at the end of treatment. 
The decrease in MAP was significantly more pronounced in S-HD compared to Na-HD (p 
= 0.03), but not compared to UF-HD (p = 0.11). Moreover, MAP decreased significantly 
during S-HD (p < 0.05), whereas it stabilised during Na-HD. The differences in MAP be-
tween S-HD and Na-HD were most pronounced after three hours of HD (p < 0.05), no-
ticeably the moment when most hypotensions occur (see figure 1). Remarkably, BV de-
crease did not improve in Na-HD compared to S-HD. In the course of treatment dBV in 
the first hour during the UF-profile was significantly steeper in comparison to the rest (p 
< 0.05 for all) due to the vigorous UF rate (40% of total UF volume), although the milder 
UF rate in the remaining hours of HD equalised the total dBV over the entire session 
(see figure 2). However, during Na-HD an effect on SV was observed, mainly in the first 
hour of dialysis. Although the overall trend of SV from start until end of HD was not sig-
nificantly different between Na-HD and S-HD (p = 0.3), the trend in the first hour of HD 
was highly significant (p < 0.01), as shown in figure 3. HR increased similarly during the 
three treatments, and, consequently, CO showed a tendency of a better preservation 
during Na-HD, although not significant (p = 0.1). SVR did not decrease significantly 
more during Na-HD, thus allowing for MAP preservation. An overview of changes in all 
hemodynamic variables is provided in Table 3. dTBW was equal between the groups in 
accordance with the similar UF volumes. However, differences in extracellular/
intracellular fluid shifts were present. In UF-HD, the decrease in ECW was nearly signifi-
cantly (p = 0.06) greater compared to S-HD and, consequently, the increase in ICW was 
more pronounced (UF-HD: 9.0 ± 1.2% versus S-HD: 6.2 ± 0.8%, p = 0.03). This suggests 
a greater intracellular water influx during the UF-profile. In contrast, during Na-HD dICW 
did not differ significantly from S-HD (Na-HD: 7.8 ± 3.7% versus S-HD: 6.2 ± 0.8, p = 
0.69). 
 
DISCUSSION 
 
In the present study we compared in hemodynamically stable dialysis patients standard 
HD to HD with a decreasing UF-profile and HD with a decreasing Na-profile, with similar 
sodium balances. During dialysis, intradialytic cardiac performance, blood volume, and 
body hydration status were monitored non-invasively. It was shown that in stable pa-
tients sodium-balanced, profiled HD does have a beneficial effect on intradialytic hemo-
dynamics, without the risk of providing patients with an accumulating sodium load. As 
was stressed in a recent report by Lam Sui Sang et al., a long-term increased mean 
dialysate sodium led to an amelioration of intradialytic symptoms in only 22% of the pa-
tients. It was accompanied by a significant increase in interdialytic complications, such 
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as hypertension and increased weight gain, together with subjective discomfort due to in-
creased thirst (17). In the present study, a better preservation of SV in the first hour of Na-
HD led to a better blood pressure during the entire session. As changes in BV, HR and SVR 
did not differ from S-HD, a direct effect of Na-profiling on cardiac contractility might be 
postulated. Another important factor could be the venous compliance, which is shown to 
be reduced in hemodialysis patients, especially when they have hypertension (18). In this 
perspective, even a minimal improvement in BV preservation might lead to enhanced SV, 
due to the sometimes delicate relation between filling of the heart and cardiac output in 
cardiac-compromised patients. This suggests that cardiac-compromised HD patients could 
benefit especially from sodium-profiled HD. In that case, a sodium balance is even more 
important, as these patients are very sensitive to sodium loading. 
An UF-profile would theoretically only lead to an better BV preservation if the mean UF 
rate is less than the individual maximum refill capacity, but in that case hypotensive epi-
sodes are unlikely to occur also during constant UF. As mono-therapy we could not prove 
any positive effect of UF-HD on BV and MAP preservation. 
In the future, more studies with different and combined sodium-balanced profiles are 
needed, in large groups of stable and unstable patients and followed for a longer period 
of time. Nowadays non-invasive monitoring applications provide the opportunity to follow 
real-time events during HD, increasing the insight in the narrow margin of optimal effec-
tive dialysis and comfortable, patient-friendly dialysis. 
In conclusion, sodium balanced Na-profiled hemodialysis improves blood pressure preser-
vation in stable hemodialysis patients without providing the patients with a sodium load. 
The effect is due to a better stroke volume preservation early in dialysis, without a signifi-
cant reduction in blood volume decrease. UF-HD, as mono-therapy, has no beneficial ef-
fect on intradialytic hemodynamics in stable patients. 
 
Table 2. Absolute hemodynamic variables at start and end of hemodialysis. 
 
All values are expressed as their mean ± SEM. No significant differences compared to 
standard HD 
 standard HD  UF-profile 
 start end start end start end 
MAP 
(mmHg) 
94 ± 7 79 ± 5 105 ±5 94 ± 7 97 ± 4 91 ± 3 
SVR  
(dyn/s/cm-5) 
2173 ± 490 2021 ± 404 2428 ± 422 2221 ± 388 2195 ± 398 2059 ± 351 
CO  
(l/min) 
4.3 ± 0.6 3.6 ± 0.4 4.1 ± 0.6 4.0 ± 0.6 4.4 ± 0.8 4.2 ± 0.6 
SV  
(ml) 
67 ± 10 50 ± 7 66 ± 12 57 ± 11 65 ± 11 54 ± 7 
HR  
(bpm) 
59 ± 4 74 ± 5 61 ± 5 76 ± 5 61 ± 4 79 ± 5 
Erythrocytes 
(1012/l) 
3.54 ± 0.21 3.80 ± 0.25 3.58 ± 0.16 3.82 ± 0.17 3.60 ± 0.15 3.88 ± 0.20 
UFtot  
(l) 
 2.77 ± 0.28  2.91 ± 0.21  2.40 ± 0.82 
Na-profile  
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Table 3 Relative changes in hemodynamic variables from the start until the end of hemodialysis 
 
* = p < 0.05 compared to standard hemodialysis 
 
Figure 1. Changes in mean arterial pressure (dMAP; mean ± SEM) during standard HD, 
Na-profiled HD, and UF-profiled HD, compared to the predialysis values. * = p < 0.05 
compared to S-HD. 
 standard HD UF-profile Na-profile 
dMAP (%) -14.6 ± 5.9 -10.2 ± 5.4 -5.2 ± 4.9* 
dSVR (%) 0.7 ± 9.8 -4.9 ± 7.7 -0.3 ± 8.8 
dCO (%) -11.0 ± 9.1 -1.6 ± 9.3 -1.0 ± 7.6 
dSV (%) -21.1 ± 7.2 -12.3 ± 9.6 -13.9 ± 6.1 
dHR (%) 12.8 ± 4.9 13.4 ± 2.6 15.7 ± 5.0 
dBV (%) -6.3 ± 1.7 -6.2 ± 1.2 -6.8 ± 2.3 
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Figure 2. Changes in blood volume (dBV; mean ± SEM) during standard HD, Na-profiled 
HD, and UF-profiled HD, compared to the predialysis values. * = p < 0.05 compared to S-
HD. 
Figure 3. Changes in stroke volume (dSV; mean ± SEM) during standard HD, Na-profiled 
HD, and UF-profiled HD, compared to the predialysis values. * = p < 0.05 compared to S-
HD. 
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The aim of this thesis was to describe hemodynamics during hemodialysis by means of 
noninvasive bedside monitoring, in order to increase understanding of in intradialytic 
hypotension. Intradialytic hypotension is a common complication during standard 
hemodialysis, with an incidence of approximately 20 percent. It causes great discomfort 
to the hemodialysis patient and reduces dialysis efficacy because of necessary interven-
tions such as interruption of hemodialysis and infusion of intravenous fluids. Because of 
changing patient characteristics with more emphasis on the elderly patient with more 
complex comorbidity, more individualized strategies to cope with intradialytic hypoten-
sion are needed. By gaining more insight in intradialytic hemodynamics, we hoped to 
enable classification of different subgroups in hypotension prone hemodialysis patients. 
In addition, tailor-made strategies to prevent intradialytic hypotension in these different 
groups could be proposed.  
 
In chapter 1 we provide an introduction into the physiology of hemodialysis-associated 
hemodynamics. Since several factors play a role whilst influencing each other, it is ob-
served that a patient-friendly bedside method monitoring hemodynamic parameters 
during dialysis would be of great value. The technique of Electrical Impedance Cardio-
graphy is explained, as well as other applied noninvasive techniques for monitoring 
blood volume and hydration status. The aims for the studies performed in this thesis 
are defined.  
 
Chapter 2 describes the noninvasive monitoring of hemodynamics during hemodialysis 
in a group of 68 chronic hemodialysis patients without manifest cardiac comorbidity. In 
35 percent of hemodialysis sessions an hypotensive episode occurred after a mean di-
alysis duration of 3 hours. The predominant finding was a paradoxical decrease in sys-
temic vascular resistance in the hypotensive group compared to a rise in systemic vas-
cular resistance in de stable group. Remarkably, differences in blood volume decrease 
or cardiac output were of minor contribution. 
 
In chapter 3 the group of hypotensive hemodialysis patients was studied in more detail 
in order to see if a subgroup division could be made based on different patterns of 
hemodynamic responses to hemodialysis. It appeared that within the group of hypoten-
sive patients a classification could be made into a subgroup with predominant decrease 
in systemic vascular resistance, and into a subgroup where the decrease in cardiac out-
put prevailed. This discrimination of subtypes of intradialytic hypotension is important 
with respect to the possible prevention strategies.  
 
However, it is questionable if the pathway leading to intradialytic hypotension is similar 
in different dialysis sessions within individuals. Therefore, in chapter 4 we examined 
the reproducibility of intradialytic hypotension subgroups by monitoring several dialysis 
sessions in the group of hypotension prone patients. Although sometimes combined, 
we observed a clinical reproducibility of type of intradialytic hypotension of approxi-
mately 70 percent. This means that in 70 percent of dialysis sessions where a hypoten-
sive episode occurred within an individual patient, the pathway of the causative mecha-
nism was identical. This adds to the idea that hemodynamic monitoring during hemodi-
alysis can contribute to a better insight in the needs of the individual patient, providing 
opportunities to tailor-made prevention strategies.  
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Since regulation of vascular tone is directed by the autonomic nervous system and auto-
nomic neuropathy is a common finding in end stage renal disease patients due to long-
term uremia, in chapter 5 we investigated the function of the autonomic nervous sys-
tem in hypotension prone and stable hemodialysis patients under normovolemic condi-
tions. We found that autonomic dysfunction is present in all hemodialysis patients, al-
though no differences between hypotension prone and stable patients could be ob-
served. It was concluded that pre-existent autonomic dysfunction is not the cause of the 
severe decrease in systemic vascular resistance in hypotension prone hemodialysis pa-
tients compared to stable hemodialysis patients.  
 
In chapter 6 the effect of sodium and ultrafiltration profiling as a preventive strategy 
was studied. Care was taken to prevent sodium loading leading to increased thirst with 
the concomitant risk of extensive fluid accumulation. The hypothesis was tested if pro-
filing of sodium or ultrafiltration leads to better a preservation of blood pressure. Ul-
trafiltration profiling did not show differences compared to standard hemodialysis. So-
dium profiling however, appeared to improve blood pressure preservation mainly by a 
better stroke volume preservation early in dialysis, without a significant reduction in 
blood volume decrease. It was concluded that sodium profiling - when a proper sodium 
balance is used - can be a useful tool in prevention of intradialytic hypotension. Further 
research is needed to determine which subgroup of hypotension prone patients benefits 
most from sodium profiling. 
 
Future perspectives 
Several preventive strategies have been proposed to diminish the occurrence of intradia-
lytic hypotension. The different strategies have different points of interaction, from in-
creasing blood volume preservation to increasing arteriolar tone or cardiac contractility. 
Applying all available strategies to all hypotension prone hemodialysis patients is ineffi-
cient and might cause unnecessary discomfort for the patient. In order to provide the 
most appropriate strategy for the individual patient, patient derived data are to be ac-
quired during hemodialysis. Closed-loop biofeedback systems are being introduced, of-
fering information on blood volume course and dialysate electrolytes such as sodium.  
However the most important hemodynamic parameters are not routinely available, such 
as stroke volume and systemic vascular resistance. Since there is a valid, non-invasive, 
bedside device for monitoring these parameters, incorporating hemodynamic monitor-
ing in daily hemodialysis will improve insight in the dynamic compensatory mechanisms 
for the individual patient. With that information, refining of subgroup classification and 
specifying of preventive strategies can occur. Although long term, slow hemodialysis is 
to be preferred with respect to hemodynamic consequences of hemodialysis, current 
demands to medical science will not easily accept a time- and cost-consuming expan-
sion of hemodialysis therapy provided today. Technology driven strategies aimed at im-
proving individualized efficiency for the hemodialysis patient will probably dominate in 
the future. 
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Bloeddrukdaling tijdens nierdialyse.  
Niet-bloedige metingen van bloedsomloopbepalende factoren. 
 
 
Achtergrond 
In Nederland zijn momenteel ongeveer 9500 mensen met chronisch nierfalen afhanke-
lijk van enigerlei vorm van nierfunctievervangende therapie. Bij ongeveer 35% hiervan 
wordt het bloed gezuiverd met behulp van nierdialyse (hemodialyse), een methode die 
sinds de vijftiger jaren beschikbaar is. Gemiddeld komt een patiënt 3 keer per week 
naar het ziekenhuis om gedurende 4 uur het bloed van overtollig vocht en afvalstoffen 
te laten zuiveren door een dialyseapparaat. Een van de belangrijkste complicaties tij-
dens hemodialyse zijn plotselinge bloeddrukdalingen (hypotensie). Deze hypotensieve 
episoden zijn zowel vervelend voor de patiënt (bewustzijnsverlies, katergevoel, kramp), 
als voor de effectiviteit van dialyse, omdat de vochtonttrekking (ultrafiltratie) onderbro-
ken moet worden en soms zelfs extra vocht toegediend moet worden. Momenteel tre-
den dergelijke bloeddrukdalingen tijdens ongeveer 20% van de dialysesessies op.  
De patiëntenpopulatie wordt in de loop der jaren steeds ouder en er is bij hen vaker 
sprake van bijkomende ziekten met een nadelige invloed op het hart- en vaatstelsel, zo-
als suikerziekte. Onderzoek in de laatste decennia laat zien dat de bloeddrukdalingen 
tijdens dialyse (intradialytische hypotensie of IDH) door diverse factoren veroorzaakt 
worden. Het onttrekken van teveel vocht in te korte tijd speelt zeker een rol, echter 
daarmee kunnen niet alle bloeddrukdalingen verklaard worden. Sommige onderzoekers 
hebben een verminderde hartfunctie aangetoond, terwijl anderen stoornissen in de ze-
nuwregulatie van de bloedvaten vonden. Omdat er zoveel verschillende factoren een rol 
spelen, die elkaar ook nog beïnvloeden, is het van groot belang om de functie van hart 
en bloedvaten tijdens dialyse te meten. Dit is mogelijk met behulp van meetapparatuur 
die via een lijn in een groot bloedvat dicht bij het hart ingebracht wordt, zoals op de In-
tensive Care veel gebeurt. Tijdens dialyse is dit echter een veel te ingrijpende en om-
slachtige methode om bruikbaar te zijn in de dagelijkse praktijk. In ons onderzoek is 
gebruik gemaakt van Elektrische Impedantie Cardiografie (EIC), een meetmethode waar-
mee de functie van hart en bloedvaten te meten is. Met elke hartslag wisselt de hoeveel-
heid bloed in de grote vaten in de borstholte. Veranderingen in deze hoeveelheid bloed 
zijn meetbaar doordat deze leiden tot veranderingen in de geleiding van een elektrisch 
stroompje dat door het EIC apparaat via 9 elektrodestickers op de huid aan de patiënt 
wordt toegediend. Deze methode is heel bruikbaar gebleken om veranderingen in 
bloeddrukbepalende factoren binnen een persoon te meten.  
 
In hoofdstuk 1 wordt de achtergrond van de problematiek met betrekking tot bloed-
drukdalingen tijdens dialyse beschreven. Tevens worden de toegepaste technieken ver-
meld. Daarnaast worden de doelen van het in dit proefschrift beschreven onderzoek 
weergegeven. De belangrijkste doelen waren het verder zoeken naar de oorzaken van 
bloeddrukdalingen tijdens hemodialyse met behulp van patiëntvriendelijke, niet-
bloedige meetmethoden, alsmede het blootleggen van eventuele verschillende oorzaken 
binnen de patiëntengroep waarin deze complicatie veel voorkomt. Uiteindelijk wordt ge-
streefd naar een meer individueel toepasbare dialysebehandeling, met minimaal verlies 
van dialyse-effectiviteit en maximaal comfort voor de patiënt.  
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Hoofdstuk 2 beschrijft de hart- en vaatfunctie tijdens een dialysesessie van 68 chroni-
sche hemodialysepatiënten, gemeten met behulp van onder andere EIC. Bij 35% ont-
stond een symptomatische bloeddrukdaling, gemiddeld na 3 uur dialyseren. De voor-
naamste bevinding was een daling van de vaatweerstand in deze hypotensieve groep, in 
tegenstelling tot een stijging bij de stabiele patiënten, zoals gebruikelijk is ten tijde van 
bloeddrukdalingen. Opvallend was dat bloedvolumedaling en verandering van hartmi-
nuutvolume een minder belangrijke rol speelden in de totale groep hypotensieve patiën-
ten.  
 
In hoofdstuk 3 werd de groep hypotensieve patiënten in detail bestudeerd, met als doel 
om een eventueel onderscheid te kunnen maken op basis van verschillende vormen van 
hart- en vaatreactie op de hemodialyse. Het bleek dat binnen de groep hypotensieve pa-
tiënten een classificatie gemaakt kon worden in een groep met voornamelijk een daling 
in vaatweerstand en in een groep waar een daling in hartminuutvolume op de voorgrond 
stond. Dit onderscheid is belangrijk voor de ontwikkeling van mogelijke strategieën om 
bloeddrukdalingen tijdens hemodialyse te voorkómen.  Verschillende oorzaken vergen 
immers een verschillende aanpak.  
 
Gezien de verschillende typen van hypotensie rees in hoofdstuk 4 de vraag of een hy-
potensieve patiënt tijdens verschillende dialysesessies steeds hetzelfde type bloeddruk-
daling liet zien, met ander woorden of het type IDH reproduceerbaar was. Om deze re-
den werden instabiele patiënten gedurende 5 hemodialysesessies gemeten. Alhoewel er 
incidenteel een combinatie van de twee typen hypotensie voorkwam, was in 70% van de 
hypotensieve episoden binnen één patiënt het type bloeddrukdaling hetzelfde. Deze be-
vinding bevestigt de gedachte dat metingen van hart- en vaatfunctie tijdens dialyse een 
belangrijke bijdrage kunnen leveren aan het in kaart brengen van de oorzaken van 
bloeddrukdalingen bij de individuele patiënt. Hierdoor kan beter ingespeeld worden op 
de specifieke behoeften van de dialysepatiënt qua preventieve strategieën.    
 
Omdat de vaatweerstand gereguleerd wordt door het onwillekeurige - of autonome -  
zenuwstelsel, hebben we in hoofdstuk 5 onderzocht hoe de functie van dit deel van het 
zenuwstelsel functioneerde in rust bij zowel stabiele patiënten als patiënten met een 
neiging tot bloeddrukdalingen. Bij mensen met nierfalen is het autonome deel van het 
zenuwstelsel frequent aangetast door langdurig hoge waarden van afvalstoffen zoals 
ureum, welke normaliter met de urine uitgescheiden zouden worden. Met behulp van 
een aantal eenvoudige oefeningen is het reactievermogen van het autonome zenuwstel-
sel betrouwbaar te testen. Het bleek dat functiestoornissen van dit autonome zenuw-
stelsel voorkomen bij veel chronische nierpatiënten, echter er werd geen verschil waar-
genomen tussen de stabiele en de hypotensieve patiënten. Er werd geconcludeerd dat in 
rust bestaande stoornissen in de functie van het autonome zenuwstelsel geen verklaring 
vormden voor het optreden van bloeddrukdalingen tijdens hemodialyse.  
 
In hoofdstuk 6 werd de effectiviteit getest van een veel toegepaste preventieve strate-
gie om IDH te voorkomen. Deze methode maakt gebruik van natriumprofilering, oftewel 
het veranderen van de concentratie zout in het badwater tijdens dialyse. Om te zorgen 
dat tijdens dialyse alleen overtollige stoffen worden uitgewassen, maar niet de nuttige 
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zouten, worden aan het badwater verschillende stoffen toegevoegd. Een van deze stof-
fen is natriumzout, dat in de bloedvaten water vanuit de weefsels kan aantrekken en 
dus kan zorgen voor een betere vaatvulling en daarmee stabielere bloeddruk. Echter, als 
er teveel natrium vanuit het badwater naar de patiënt gaat zorgt dit na de dialyse voor 
meer dorst en een te grote vochtinname. Bij een volgende dialyse moet er dan een (te) 
grote hoeveelheid water onttrokken worden, wat weer een hoger risico op hypotensie 
met zich meebrengt. Door de natriumconcentratie te veranderen van hoog in het begin, 
naar laag aan het eind van dialyse, kan gezorgd worden voor het belangrijke voordeel 
van extra bloeddrukondersteuning, zonder bijwerkingen als zoutoverbelasting.   
In ons onderzoek zorgden we voor een gelijkblijvende zoutbelasting, terwijl de natrium-
concentratie varieerde op verschillende wijzen tijdens dialyse. Ook de snelheid van 
ultrafiltratie – of vochtonttrekking – werd gevarieerd, wat echter geen beter bloeddruk-
behoud opleverde. Het natriumprofileren verbeterde de bloeddruk wel ten opzichte van 
een standaard hemodialyse. Dit was te danken aan een verbeterd slagvolume van het 
hart, zonder een significante vermindering van bloedvolumedaling. Er werd geconclu-
deerd dat natriumprofilering een nuttige strategie ter voorkoming van IDH zou kunnen 
zijn. 
 
Toekomstperspectief 
Vele preventieve strategieën zijn reeds voorgesteld om het optreden van intradialytische 
hypotensie te verminderen. De werkingsmechanismen verschillen van verbeterd behoud 
van bloed volume, tot verhoging van vaatweerstand en verbetering van de contractiliteit 
van het hart. Het toepassen van diverse strategieën tegelijkertijd bij alle patiënten met 
neiging tot IDH is inefficiënt en kan leiden tot onnodige discomfort voor de patiënt. Om 
de meest geschikte strategie per patiënt te bepalen is het noodzakelijk om individuele 
gegevens over de functie van hart en vaten tijdens hemodialyse te verzamelen. Alhoewel 
er reeds terugkoppelingssystemen op de dialyseapparaten beschikbaar zijn, worden de 
belangrijkste bloeddrukbepalende factoren nog niet routinematig gemeten. Met de Elek-
trische Impedantie Cardiograaf  is een methode beschikbaar waarmee deze variabelen 
aan het bed op patiëntvriendelijke wijze betrouwbaar gevolgd kunnen worden. Routine-
matig gebruik hiervan zal het inzicht in de individuele behoeften van de dialysepatiënt 
vergroten, leidend tot een betere toepassing van beschikbare preventieve strategieën. 
Alhoewel langere en daarmee geleidelijker verlopende dialysesessies veel bloeddruk-
schommelingen zouden kunnen voorkomen, is dit qua beschikbare tijd en plaatsen niet 
altijd realiseerbaar. Technische verbeteringen en geïndividualiseerde zorg kunnen die 
leemte opvullen. Daarop zal toekomstig onderzoek gericht moeten zijn. 
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Ook ik heb - wat langer dan gewenst - mogen ervaren dat de weg der wetenschap, soms 
mooi, maar vaak ook lang en eenzaam kan zijn. Steun van anderen is onontbeerlijk. 
 
Allereerst wil ik de patiënten danken die mijn vele apparatuur en langdurige aanwezig-
heid duldden, terwijl ze aan het dialyseren waren. In de vele gesprekken die daaruit 
voortkwamen heb ik een diep ontzag gekregen voor de impact die hemodialyseren heeft 
op het dagelijks leven van patiënten. Groot respect heb ik voor de wijze waarop zij daar-
mee om weten te gaan. 
 
De verpleegkundigen en medewerkers van de dialyseafdelingen in het VUMC en in Dia-
tel dank ik voor de soepele samenwerking, maar vooral ook de belangrijke gezelligheid 
tijdens al die dagen op de unit. Mia Roggekamp en Paul Stevens dank ik voor de gast-
vrijheid die ik genoot in Diatel Amsterdam. 
 
Mijn promotor, prof.dr. P.M. ter Wee, beste Piet, laagdrempelig en joviaal, jij kwam altijd 
met een opklaring als er weer eens een depressie over het schrijfproces lag. Ik ben blij 
dat we dit samen toch tot een goed eind hebben weten te brengen. Het is me een on-
voorstelbaar genoegen om onder jou te promoveren.  
 
Mijn co-promotor, dr. P.M.J.M. de Vries, beste Peter, jij bent de initiator van dit alles. Jij 
bood mij de gelegenheid op de ‘de Vries-trein’ te stappen en bent, zelfs toen je al lang 
weg was uit de VU, altijd bereid geweest mijn inbreng vlot van gedegen commentaar te 
voorzien. Jouw vindingrijkheid is opmerkelijk. Voor de problemen ter grootte van ber-
gen die ik regelmatig op mijn weg zag, leek jij immer de oplossing zo uit je mouw te 
schudden, mij achterlatend met de vraag wat er toch zo moeilijk geweest was. 
 
Prof.dr. A.J.M. Donker. Geachte professor Donker, ik voel me bevoorrecht u nog meege-
maakt te mogen hebben als ‘voorganger’ in de beginfase van het onderzoek. Uw ener-
gie en enthousiasme gecombineerd met een ontzagwekkende werklust zijn een voor-
beeld. Ik hoop oprecht dat u kunt genieten van uw emeritaat. 
 
Prof.dr. R.M. Heethaar, prof.dr. F.C. Visser, prof.dr. K.M.L. Leunissen, prof.dr G.J. Tan-
gelder, prof.dr. W.P.F. Fetter, mw.dr. M.P.C. Grooteman en dr. R. Zietse. Als leden van 
de promotiecommissie wil ik u danken voor de moeite die u genomen hebt om mijn 
proefschrift te beoordelen en te opponeren tijdens de verdediging.  
 
Prof.dr. W.P.F. Fetter, kinderarts-neonatoloog. Beste Willem, jij hebt een constante rol 
gespeeld in mijn opleiding tot kinderarts. In den beginne reikte jij mij de artsenbul uit, 
waarna ik kon beginnen met de opleiding. Tijdens de neonatologiestage heb ik veel van 
je geleerd, als je jouw grote parate kennis vaak middels een anekdote tentoonspreidde. 
De manier waarop jij het –inmiddels verkregen- opleiderschap weet te combineren met 
nog grote klinische activiteit is bewonderenswaardig. Jouw deur staat altijd open en je 
geeft je arts-assistenten het gevoel daadwerkelijk het beste met ze voor te hebben. 
 
Prof.dr. J.J. Roord, kinderarts-infectioloog. Beste John, als mijn –aanvankelijke- opleider 
Kindergeneeskunde ben jij pas in een late, maar ook moeizame fase bij het proefschrift 
betrokken geraakt. Het combineren van klinische opleiding en het schrijven van een 
proefschrift was niet altijd gemakkelijk. Jij hebt, samen met Reinoud Gemke, getracht 
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ruimte te scheppen om de laatste zware loodjes over de eindstreep te tillen. Met name 
de voortgangsgesprekken met filosofische inslag zijn me bijgebleven. Het huis met de 
vijf kamers is een gevleugelde uitdrukking van je. 
 
A.F. Nagelkerke, kinderlongarts, beste Ad, als mijn mentor ben je van grote motiveren-
de waarde geweest. Oprecht geïnteresseerd en betrokken bespraken we heel wat 
‘levenswaardigheden’, al fietsend door bosrijk Amstelveen. Jouw gastvrijheid en het ge-
voel dat je vierkant achter me stond heb ik erg gewaardeerd. 
 
Dr. A.M. van Furth, kinderarts-infectioloog. Beste Marcelien, met name in de fase van de 
eindsprint heb jij mij terzijde gestaan als ‘mental coach’. Wars van nodeloze complexi-
teit wist jij de weg recht te houden en het moraal hoog. Veel dank daarvoor. 
 
Dr. P.J. van Dijken, kinderarts-hemato-oncoloog. Beste Pim, als mijn opleider in Tilburg, 
kreeg ook jij te maken met mijn hindernissen van ‘onderzoek tijdens kliniek’. Als dui-
zendpoot in de vakgroep had je veel aan je hoofd, maar dat weerhield je er niet van om 
mij keer op keer van eerlijk en integer advies te voorzien. Met name van je analytisch 
vermogen en gestructureerd denken heb ik veel geleerd. 
 
De mede-onderzoekers van het eerste uur, Peter Kunst, Anton Vonk Noordegraaf, Harm-
Jan Bogaard, Harald Woltjer en Jean-Paul de Vries zijn inmiddels allang succesvol uitge-
vlogen naar uiteenlopende gebieden. Die begintijd was belangrijk voor het gevoel deel 
uit te maken van een groep. Als laatste der Mohikanen zal ik het licht uitdoen in de Me-
ander. 
 
Dr. B.J. ten Voorde, medisch fysicus. Beste Ben, inmiddels al enige tijd geleden bracht jij 
mij de beginselen bij van de autonome functietesten en de digitale verwerking daarvan. 
Mijn dank daarvoor. 
 
Ada van Dijk, secretaresse Nefrologie, heeft in de laatste stressvolle afrondingsfase een 
aantal logistieke strubbelingen prettig weten te stroomlijnen. 
 
Mijn collega’s van de Kindergeneeskunde dank ik voor hun interesse in mijn ‘project’ en 
de ruimte die ik kreeg om het boekje af te maken. Michiel Schreuder en Michiel Ooster-
veld, door het delen van de faciliteiten in de Meander voel ik mij inmiddels echt een Me-
anderthaler. Nicole Ramakers – van Woerden heeft mijn ‘steenkolen’-Engels nog een 
beetje bij weten te schaven en Rogier de Jonge, gewaardeerd jaargenoot en whizzkid, 
heeft vele computerproblemen opgelost en de layout verfraaid. Marijn Vermeulen, Eveli-
ne Berghout en Alike Kamerbeek, als ‘Gigantjes’ hebben we meer diepgang in gezellig-
heid dan in de Nelson weten te vergaren, maar dat was zeker zo belangrijk. Marijn, sa-
men opgegroeid in de kindergeneeskunde, ik hoop van harte nog eens bij jouw promo-
tie te kunnen zitten.  
 
Mijn gewaardeerde vrienden, Tanja, Sander, Annette, Edou, Dorien, Bregje en Cecile, van 
Gieter-tijd tot kinder-tijd, we gaan al even mee. Ik ben blij dat jullie af en toe toch nog 
naar het boekje durfden te vragen. Ons samenzijn, alhoewel tegenwoordig wat minder 
frequent, draag ik een warm hart toe. Edou en Sander, ik ben blij dat jullie als mijn para-
nimfen mijn verdediging enige lengte en gewicht geven. 
Dankwoord 
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Jeroen en Frank, vrienden sinds de kleuterschool, een tijd zonder jullie kan ik me niet 
eens voorstellen. Dat de mannenavondjes nog maar lang in sigarenwolken gehuld mo-
gen blijven. 
Marije, dat we nog maar veel Amsterdamse restaurantjes mogen uitproberen. Jij mag 
hier niet onbenoemd blijven. 
 
Lieve Miranda, als mijn jonge zusje ben je teruggekeerd naar onze geboortegrond, met 
je gezin, wat je geweldig afgaat. Arno, als ik net zoveel avonden als jij aan het werk was 
geweest, dan was dit boekje waarschijnlijk een stuk eerder af geweest. Lieve Mirte en 
Siebe, ik hoop dat jullie je speels enthousiasme nog lang mogen behouden. Dikke knuf-
fels. 
 
Lieve pa en ma, jullie zorgden niet alleen voor de beste basis die een kind zich kan wen-
sen, tot op de dag van vandaag ben ik gelukkig met de hechte band die we hebben. Ik 
hoop jullie nog lang in goede gezondheid bij me te houden. 
 
Linda, lieve mop, geen zorgzamer persoon dan jij. Liefde en vertrouwen krijgt bij jou 
een diepere dimensie. Op naar een volgende fase. 
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Bart Straver werd op 6 mei 1972 geboren in Alkmaar. Van 1984 tot 1990 doorliep hij 
het Murmellius Gymnasium te Alkmaar, waarna aangevangen werd met de studie Ge-
neeskunde aan de Vrije Universiteit te Amsterdam.  
Na het doctoraalexamen in 1995 werkte hij 3 jaar als onderzoeker op de afdeling Nefro-
logie in het VUMC (hoofd: prof.dr. A.J.M. Donker, later prof.dr. P.M. ter Wee), waar uit-
eindelijk de basis gelegd werd voor het hier beschreven onderzoek.  
Van 1998 tot 2000 werden de co-assistentschappen doorlopen (cum laude) waarna hij 
een korte periode als keuringsarts gewerkt heeft. 
Per 2001 startte hij de opleiding Kindergeneeskunde in het VUMC (opleider: prof.dr. J.J. 
Roord, later prof.dr. W.P.F. Fetter), waarbij anderhalf jaar doorgebracht werd in het St. 
Elisabeth Ziekenhuis te Tilburg (opleider: dr. P.J. van Dijken). 
Sinds oktober 2005 is hij in opleiding tot kindercardioloog in het AMC te Amsterdam 
(opleider: prof.dr. J. Ottenkamp). 
